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Outside of some classical morphological images there is very little information on cell types 
and molecular events of the early post-implantation stages of human development. These 
stages are referred to as the pre-lacunar period of the trophoblastic plate and the lacunar or 
pre-villous stages, and exist from the time of embryo implantation to approximately five days 
post-implantation. The vast majority of cells consist of cytotrophoblast and 
syncytiotrophoblast cells, which act   as   the   “front   line”   of   the   fetal interactions with the 
maternal compartment and deeply invades the endometrial stroma. The syncytiotrophoblast 
that exists during this early implantation period was suggested to be invasive and similar, but 
distinct, from the more well-studied villous syncytiotrophoblast of the mature placenta. While 
it is virtually impossible to study this period of development directly, with their propensity to 
give rise to the trophoblast lineage, human embryonic stem cells (hESC) provide the 
opportunity to model these events in a cell culture dish. 
It has been shown that a combination of BMP4 induction and FGF receptor inhibition leads 
hESC to differentiation along the trophoblast lineage. I have combined this with a subsequent 
high content screen (HCS) of growth factors and cytokines to explore the potential of these 
cells to give rise to trophoblast sub-populations. Specifically, the HCS was initiated on hESC 
that had first been induced to differentiate/commit to the trophoblast lineage for 3 days of 
BMP4/SU5402 treatment. Eleven growth factors and cytokines were chosen based on a 
review of the literature and an examination of receptor expression in mRNA-seq data 
generated from hESC-derived trophoblast. Over 72 hours and in a 96 well format, whole cell 
and nuclei stains were utilized to capture cell features (e.g. cytoplasm to nuclei ratios) to 
determine responses to these growth factors and cytokines. I identified the BMP4, epidermal 
growth factor (EGF), and keratinocyte growth factor/fibroblast growth factor 7 (KGF/ FGF7) 
resulted in increased multinucleated cells. Subsequently when combined, these molecules led 
to greater than 90% of cells becoming multinucleated.  
Mining of mRNA-seq data suggests invasive molecules are expressed on hESC-derived 
syncytiotrophoblast from BMP4/EGF/FGF7 combinatorial treatment. I confirmed the 
 xv 
expression of invasive features including membrane-type matrix metalloproteinase type 1 
(MT1-MMP/ MMP14) in invadopodia-like structures, which are also markers of metastatic 
cancer cells. This model of hESC-derived invasive syncytiotrophoblast provides an avenue to 
begin to understand the mechanisms of invasiveness in the implanting human embryo, which 












1.1.The Human Placenta and Pregnancy Pathology in Early Implantation 
A reproductive system is essential for any organism to retain their existence in nature. 
The sexual reproductive system in vertebrates is generally classified into three main 
types, oviparity, viviparity, and ovo-viviparity. Among these types, the eutherian 
mammals use viviparity (i.e. giving birth to living offspring that develop within the 
mother's body). While viviparity is not restricted to eutherian mammals, these animals 
establish a more complex form of viviparity, which involves placenta formation 
(placentation) and is termed placental viviparity (Lodé, 2012). In placental viviparity, 
a placenta is formed both from extra-embryonic cells of the conceptus/embryo and 
from maternal endometrial cells. The placenta is essential for maintaining successful 
pregnancy. Embryo development and placental formation takes place within the 
uterus through embryo-endometrial interactions. The initial stages of this embryo-
endometrial interaction are referred to as implantation. In the human, blastocyst 
implantation is highly invasive with the embryo invading deeply into the 
endometrium wall. This process is precisely coordinated between the implantation-
competent blastocyst and the hormonally prepared receptive endometrium (Psychoyos 
et al. 1995). This brief period (~3 days of the 28 day menstrual cycle) where the 
endometrium is receptive to the embryo is referred to as the “window of 
implantation”,   outside of this window the endometrium will not be responsive 
towards blastocyst presence and implantation will fail (Klentzeris, 1997). 
Besides the temporal coordination between the embryo and endometrium during the 
implantation process, there are various other factors that generally affect successful 
pregnancy, including genetics, maternal nutrition, and environmental exposure. 
Recurrent miscarriage which is estimated to affect 1% of fertile couples and is defined 
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as three consecutive pregnancy losses, has been determined to have a genetic 
component (Branch et al., 2010; Daher et al., 2012). Both maternal nutrition 
deficiency and over-nutrient have been associated with various abnormal pregnancy 
outcomes and various metabolic diseases in the fetus and at later stages of life 
(Rinaudo and Wang, 2012; Vieau, 2011; Yajnik and Deshmukh, 2012). Intra-Uterine 
Growth Restriction (IUGR) or Fetal Growth Restriction (FGR), which results in an 
underweight fetus, is a common outcome of maternal nutrition deficiency (Delahaye 
et al., 2008, while maternal insulin resistance and hyperglycemia are commonly 
observed outcomes from maternal obesity (Raghow, 2012). These outcomes are,in 
part, thought to be mediated by the placenta. 
Various pregnancy pathologies have been reported occurring as a result of 
placentation and implantation defects, such as pre-eclampsia, placenta accreta 
(abnormally deep attachment of the placenta), and fetal growth restriction (Khong, 
2008; Scifres and Nelson, 2009; Toal et al., 2007). The placenta is a transient organ 
that holds an essential role in pregnancy. It is responsible for supplying nutrition to 
and waste removal from the developing embryo from the time of blastocyst 
implantation through to term of pregnancy. In addition, throughout this period the 
placenta plays an important role in protecting the fetus from maternal immune 
rejection as the fetus is a combination of maternal and paternal genomes and is thus 
allogeneic (or a semi-allograft) to the mother (Kumpel and Manoussaka, 2012).  
The complex coordination of signals during implantation begins with receptivity 
being established through ovarian endocrine hormones acting upon the endometrium, 
which presumably (as they are not well characterized) subsequently expresses signals 
of its own that attract the blastocyst for implantation. Signaling is bidirectional as the 
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implanting blastocyst, specifically the trophoblast, begins to secrete its own signals. 
The best characterized of these is human chorionic gonadotrophin (hCG) (Shi and 
Massagué, 2003; Yang et al., 2003), a hormone essential for maintaining pregnancy 
by signaling to and maintaining the corpus luteum and its production progesterone 
which blocks menstruation (Järvelä et al., 2008). During this time the trophoblast 
continues to differentiate and embed/invade into the endometrial stromal layer. 
However, any mistake or failure during this period can result in various gestational 
pathologies, for example spontaneous abortion, recurrent miscarriage, or gestational 
trophoblastic diseases (Monchek and Wiedaseck, 2012; Wang et al., 2003). 
Spontaneous abortion (i.e. miscarriage) is defined as unplanned and unexpected 
termination of pregnancy. It has been estimated that 50-70% of spontaneous abortions 
occur during first trimester, with approximately 90% of these occurring very early (i.e. 
pre-clinically) unbeknownst to the mother (Boklage, 1990; Edmonds et al., 1982). 
Chromosomal anomalies, likely arising during oocyte maturation or early post-
fertilization, are thought to account for greater than 50% of early pregnancy loss 
(Edwards, 1986; Wilcox et al., 1999).  
Other early embryonic implantation pathologies related to trophoblast disregulation 
are the gestational trophoblastic diseases, including invasive moles, hydatidiform 
moles, gestational choriocarcinoma, and placental site trophoblastic diseases (Lurain, 
2010; Seckl et al., 2010; Soper, 2006). Hydatidiform mole originates from the Greek 
word   “hydatisia”   meaning   drops   of   water   and   latin   word   “mola”   meaning   false  
conception, and results from abnormal growth of the trophoblast (Szulman and Surti, 
1978). For unknown reasons hydatidiform moles have higher prevalence in Asian 
populations, with incidence as high as 2.0 per 1000 pregnancies in Japan and South-
East Asia compared to 0.57-1.1 per 1000 pregnancies in Europe, North America, and 
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New Zealand (Atrash et al., 1986). These moles originate from a defective union of 
ovum and sperm, leading to atypical proliferation of villous trophoblastic cells that 
rapidly fill the uterine space and result in placental-site trophoblastic tumors (Sebire 
et al., 2003; Sebire, 2010). Hydatidiform mole can be classified into two types, 
complete moles or partial moles, the former occurs when a haploid sperm fertilizes an 
empty ovum and results in the absence of fetal tissue. Partial moles caused when a 
normal ovum is fertilized by two sperm resulting in congenital abnormalities in the 
fetus (Berkowitz and Goldstein, 2013; Jain, 2005). Consistent with an increase in 
trophoblast proliferation abnormally elevated hCG levels have been reported in 
hydatidiform moles (Menczer et al., 1980; Ozturk, 1991). 
Morbidly adherent placenta represents another class of placental pathology and, as the 
name implies, results from an abnormal implantation of the placenta into the uterine 
wall. Based on the severity, these can be classified into three types, placenta accreta, 
increta, and percreta with overly invasive trophoblast directly adhering to the 
myometrium, invading the myometrium, or invading beyond the myometrium, 
respectively (Hertig, 1937). Placenta accreta is the most common of the three, 
representing 75% of cases (Miller et al., 1997). While a number of hypotheses have 
been proposed to explain their pathology, the dominant view is of abnormal 
vascularization resulting from the scaring process after cesarean surgery with 
secondary localized hypoxia, which leads to defective decidualization and excessive 
trophoblastic invasion (Strickland and Richards, 1992; Tantbirojn et al., 2008). 
Resulting clinical complications include damage to local organs, post-operative 
bleeding, amniotic fluid embolism, acute respiratory distress syndrome, multi-system 
organ failure, to maternal death (Eller et al., 2011). 
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Inadequacies in trophoblast invasion can lead to several pathological outcomes, such 
as miscarriage, intrauterine growth restriction (IUGR), premature delivery, and Pre-
eclampsia, which is one of the leading causes of maternal and neonatal mortality 
worldwide (ACOG, 2002; Sibai et al., 2005). Pre-eclampsia is described as a 
hypertensive disorder in pregnancy, which is characterized by the onset of proteinuria 
and hypertension beginning as early as the 20th week of gestation (Brown et al., 
2000; Noris et al., 2005). Additional manifestations in pre-eclampsia include 
haemolysis, elevated liver enzymes, and low platelets or HELLP syndrome, which 
might develop into placental abruption, renal failure, pre-term delivery and even fetal 
or maternal mortality (Uzan et al., 2011). Pre-eclampsia is thought to initiate with 
placental dysfunction in the first trimester, specifically defects in invasion and 
modification of maternal spiral arteries by a subset of trophoblasts called extravillous 
trophoblast (Brosens et al., 2002; Meekins et al., 1994). This then leads to an 
inadequacy of blood flow into the placenta which is thought to respond by releasing 
vasopressors. These factors raise maternal blood pressure resulting in a change in the 
perfusion pressure, resistance index, flow velocity, and plasma volume leading to 
hyperdynamic circulation and endothelial activation (Alexander et al., 2001; Cudihy 
and Lee, 2009). While the exact molecular mechanism initiating this series of events 
within the first trimester extravillous trophoblast is still unclear there is active 
research to discovery predictive biomarkers present in maternal serum prior to the 
clinical onset of the disease in the second trimester (Smets et al., 2006). 
All of these above mentioned pregnancy pathologies emphasize the need to better 
understand their etiology. The cell lineage at the core of these is the trophoblast  
which emerges from the outer cells of the later stage pre-implantation embryo and 
mediates attachment, invasion, and eventual placental formation (Aplin, 2000). 
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Despite the clinical importance of the human trophoblast, relatively little is known of 
its molecular development, primarily due the inaccessibility of this tissue. What is 
known is described in the following literature review.  
Besides its common function in maternal-fetal nutrition transfer, it is also suggested to 
play an important role in early embryonic implantation, especially early endometrial 
wall invasion (Enders et al., 1983; Enders and Lopata, 1999).  
1.2. Origin and Development of the Human Placenta 
Formerly, from a functional perspective, the placenta was commonly viewed as an 
organ   that   had   a   little   impact   on   a   person’s   life.   However,   the   placenta   is   now  
considered an important factor in determining the outcome of pregnancy and its 
influence on human health can extend long beyond birth (Gagnon, 2003; Vieau, 2011). 
Another intriguing fact of the placenta is that it is extremely diverse with radical 
morphological and anatomical differences between mammalian species (Carter and 
Mess, 2007). In this section I present background information on the placenta, its 
development and function, and our current molecular understanding. Further details 
about syncytiotrophoblast development, which is the focus of my thesis, will be given 
in a later section (Chapter 1.4). 
The term Placenta comes  from  the  Greek  meaning  “flat  cake”.  The  classical Greeks 
recognized its importance in fetal nutrition, thus naming the innermost membrane 
surrounding the fetus as amnion (bowl) and outermost membrane as chorion 
(membrane). Aristotle the classical Greek philosopher-biologist may have been the 
earliest to use the term chorion (Aristotle, 1831-1870). However, because many of his 
studies or ideas are based on findings in animals other than human, his findings threw 
up a lot of confusion and controversies. Even so, he did a lot to establish the scientific 
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aspects of the study of fetal membranes. After the passage of several centuries, 
anatomy studies of the placenta started to re-emerge during the Renaissance period. 
Leonardo da Vinci (1492-1519) presented an outstanding illustration of the human 
body by combining the science and aesthetic in his anatomical studies. He described 
the uterus and its blood vessels in addition to the fetal membranes and umbilical cord 
(placenta) with its vessels (da Vinci, 1913). However, he incorrectly described the 
placental attachment for being cotyledonary (as in an ox); even though he correctly 
depicted the fetal blood vessel as not being continuous with the mothers (O'Malley & 
Saunders, 1952). The most widely accepted modern definition of the placenta is the 
one  given  by  Mossman  (1937):  “An  opposition  of  parental  (usually  maternal)  side,  for 
the  purposes  of  physiological  exchange”.  The  placenta  acts  as  a  connection  site  where  
there is an extensive mixture of fetal and maternal tissues. The maternal tissue usually 
consists of a uterus or oviduct derivative, while the fetal tissue is commonly derived 
from the Trophectoderm/ Trophoblast. Even though the maternal-fetal connection is 
very close, the degree of apposition may vary among species (Carter, 2007). Thus, in 
terms of function as a transporting epithelium between the fetus and the maternal side, 
in certain species it may have evolved to develop specific methods to uptake nutrition. 
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Figure 1.1. The timeline of human embryonic development prior to 
implantation (©Terese Winslow). 
(http://stemcells.nih.gov/info/scireport/pages/appendixa.aspx)  
The development of the human placenta is a unique and complex process. Due to 
ethical and technical concerns, it is almost impossible to investigate human in vivo 
implantation and placenta development. Therefore, full knowledge of human embryo 
implantation and placentation remain elusive, but emphasizes the need for in vitro 
systems to address this gap in understanding. Before placentation takes place, 
successful implantation depends on synchronization between the developmental 
stages of the embryo itself and the complex series of molecular and cellular events 
that are induced in the pregnant uterus by paracrine and autocrine regulators (Krüssel 
et al., 2003). 
Preparation for embryo implantation begins at cleavage stage. In order to permit the 
formation of inner cell mass and trophectoderm cells, successive cleavages must 
generate sufficient cells prior to the blastocyst stage. The blastocyst consists of the 
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inner cell mass, which later forms the embryo proper, and this is surrounded by an 
outer layer of epithelial cells called Trophectoderm or trophoblast (Enders et al., 
1997; Plachot, 2000). The placenta originates from the trophectoderm. The 
trophectoderm later forms the cytotrophoblast (or trophoblast stem cell) which then 
becomes either the villous cytotrophoblastic cells which will proliferate and 
differentiate by fusion to form the syncytiotrophoblast, or they will stream out of the 
placental villous to form mononuclei multilayered invasive extravillous 
cytotrophoblastic cells. 
To initiate implantation the  blastocyst   “moves”   towards   the   receptive  uterine cavity 
(Gellersen et al., 2007). The process of implantation begins six to seven days after 
fertilization and consists mainly of three stages (Norwitz et al., 2001; Vigano et al., 
2003). Apposition is the first stage indicating the initial, still unstable, adhesion of the 
blastocyst to the endometrial wall. At this stage, the micro protrusions from the apical 
uterine epithelium surface called the pinopodes, interact with microvilli on the apical 
syncytiotrophoblast surface at the polar end of the blastocyst (Lopata et al., 2002; 
Nikas and Aghajanova, 2002). The next step is adhesion, which reveals an increased 
direct contact between the blastocyst and the endometrial epithelium with the 
embryonic pole positioned toward the epithelium. The last stage of implantation is the 
invasion process, which begins with the penetration of the syncytiotrophoblast 
through the uterine epithelium and is followed by the infiltration of the mononuclei 
cytotrophoblasts invading the entire endometrium, the inner third of the myometrium 
and eventually the uterine vasculature to establish the maternal blood flow. 
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Figure 1.2. The Barnes embryo from Carneige Institute collection. A 
section of a human embryo from the early stages of implantation, 
estimated to be 12 days post conception or 5 days post-implantation. 
The figure was modified from Hamilton (Hamilton et al., 1943). 
During the implantation period, the trophoblast plays an important role in attaching 
the blastocyst to maternal uterine (endometrium) wall (Red-Horse et al., 2004). 
Moreover, by examining the very few sections available for this virtually inaccessible 
period of development (Figure 1.2), the trophoblast, especially the 
syncytiotrophoblast appears to take part in endometrium wall invasion (Hamilton et 
al., 1943). As shown in the Figure 1.2, the syncytiotrophoblast is seen in direct 
contact with the maternal tissue including the maternal uterine gland (marked by 
square), these glands are an important nutrition source for fetal development during 
the pre-placental period. At the time these rare samples were collected (1930s-1950s) 
current technologies were not available, thus we only have of morphological 




Later studies have used these earlier morphological data as a guide and have reported 
more detailed descriptions from different criteria of the trophoblasts roles during 
implantation (Beck, 1976; Kimber, 2000; New, 1978). After implantation, the 
trophoblast then will further differentiate into various distinct cell types, for example 
Cytotrophoblast and Syncytiotrophoblast (multinucleated trophoblast cells) that 
acquire their own functions in order to form a proper placenta (Huppertz, 2008). After 
this initial establishment of the embryo deeply embedded in the maternal 
endometrium and surrounded by extra-embryonic cells (predominantly 
syncytiotrophoblast and cytotrophpoblast), the cytotrophoblast will subsequently give 
rise to extravillous trophoblast. These are the cells that invade the endometrial blood 
vessels (spiral arteries), remodeling them to eventually establish maternal blood 
circulation into the placenta. There is no direct vascular connection between the 
mother and embryo/fetus, whether it is histiotrophic or, after blood flow is established, 
hemotrophic, all nutrients pass directly through the syncytiotrophoblast (Bilban et al., 
2010). The extravillous cells that invade the spiral arteries are the most well-studied 
invasive trophpoblast cell as they are accessible from the mature placenta, nothing is 
known beyond morphology of the syncytiotrophoblast that initially invades the 
endometrial stroma during implantation. To be clear, these syncytiotrophoblast should 
be considered distinct from the non-invasive syncytiotrophoblast that line the 
chorionic villous in the mature placenta. The later I term the villous 
syncytiotrophoblast and the former, the primitive syncytium. It is the primitive 
syncytium that is the focus of my thesis, where I aim to establish a cell-based model 




1.2.1 The Hourglass Model of Evolution and Development 
It is becoming evident that early development, implantation, and placentation in the 
primates is quite unique compared to other mammals. This is in line with recent 
theories in the field of evolution and development (evo-devo). A number of theories 
(four main ones) have been proposed to address the relationship between evolution 
and  development.  The  first  was  the  “Early  Conservation”  model  proposed  by  German 
embryologist Karl Ernst von Baer in 1828. He first noted a striking similarity among 
animal species during periods of their embryonic development. von Baer came to the 
conclusion that at early stages of development, animal embryos from different species 
share the most resemblance between one another and, as development proceeds 
differences are accumulated (von Baer, 1828). This,   von  Baer’s   third   law,  provided  
evidence  supporting  the  theory  of  “Common  Descent”  (1859),  Darwin considered this 
embryonic conservation between species as reflecting a lack of adaptive opportunities 
(environmental constraint) available to the embryonic stages, whereas the adult form 
adapted to environmental variance. The caveat to this is that von Baer based his 
observations on post-gastrulation embryos, the similarity he described refers to the 
mid-gestation embryogenesis and not the very early stages (von Baer, 1828). 
A second theory aimed at understanding evo-devo  is  the  “Stepping-stone”  model. In 
1922, Walter Garstang argued the root of adult morphological uniqueness was a 
consequence of the sequential addition of adaptation upon the foundations of older 
characters, older characters were retained to ensure the proper development of the 
more recent adaptations (Garstang, 1922; Holland, 2011). 
Technological advances in microscopy during the 20th century enabled greater study 
of embryonic development, particularly the earlier (i.e. smaller) stages. These studies 
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clearly indicated a diversity of form in early development and showed that only later 
in development morphological conservation was greatest, a stage specifically referred 
to  as  the  “phylotypic  period”.  In  1995,  a  combination  of  the  arguments  from  Duboule  
and   Raff   were   summarized   into   the   “Hourglass   Model”.   The   Hourglass   model  
proposes that morphological conservation was greatest within mid-embryogenesis, the 
phylotypic period, whereas earlier and later in development varied more substantially 
(Figure 1.3). Early embryonic differences might be a consequence of various 
reproductive strategies while later differences resulted in specializations to diverse 
niches of the adult organisms across different species (Duboule, 1994; Raff, 1996). 
The conservation at the phylotypic stage was argued to be due to developmental 
constraint, specifically the precise coordination between patterning and growth at this 
stage involves a sequence of temporal and spatial activation of genes highly sensitive 
to disturbances (Duboule, 1994; Raff, 1996). 
In this context of the Hourglass model of evolution and development, it is then not 
surprising that there are remarkable morphological differences in early embryonic 
development between mammals, including embryo implantation strategies and 
placentation between species. As can be seen in Figure 1.4, there is a significant 




Figure 1.3. The comparison of four embryonic conservation models. The 
dashed   line   in   von  Baer’s   classic  model reflects that the observations 
were based on the post-gastrulation embryo. The dashed line in the Poe 
& Wake model represents the conservation pattern over a limited period 
of time whereas the unbroken line marks the absence of a particular 
pattern of conservation (i.e. all developmental periods are equally likely 
to diverge). Modified from (Kalinka et al., 2010). 
Developmental timing differences include the zygotic/embryo genome activation 
(ZGA/EGA); in the mouse this starts at the 2-cell stage (Flach et al., 1982) whereas in 
humans it is on day 3 at ~4- to 8-cell stage (Taylor et al., 1997; Vassena et al., 2011). 
The timing of compaction and blastocyst formation also differs significantly, with 
human embryos showing delayed blastocyst development (days 5-6) compared with 
mouse embryos (days 3-4) (Niakan et al., 2012). In the mouse, the TE generates a 
proliferative stem cell pool of extra-embryonic ectoderm (ExEc) cells that will further 
differentiate into polyploid trophoblast giant (TG) cells. By contrast, human TE gives 
rise to cytotrophoblast or trophoblast stem cells that will differentiate into two major 
subtypes, extravillous trophoblast (EVT) and villous cytotrophoblast (VCT) cells. The 
VCT will then fuse to form multinucleated syncytium (Syn). 
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Figure 1.4. The timeline and morphology comparison between mouse 
(top) and human (bottom) embryo (Niakan et al., 2012). The differences 
between two systems make the early embryonic development and 
implantation in human incomparable to other systems. 
The blastocyst comprises mainly two types of cells, the inner cell mass (ICM) that 
will develop into proper embryo and the trophectoderm or the outer layer of 
blastocyst that will give rise to extraembryonic tissue or placenta. Based on blastocyst 
morphology, two types of trophectoderm can be defined, the polar trophectoderm in 
contact with ICM and mural trophectoderm surrounding the blastocoel (Chávez et al., 
1984; Gardner, 2000). The ‘Zona  breaker’   cells   in  mural   trophectoderm  control   the  
hatching of the human blastocyst from their zona pellucida, this is an essential step 
after which the trophoblast will begin to attach and invade the uterine epithelium 
(Sathananthan et al., 2003). The polar trophectoderm is in a position to control 
embryonic development by producing factors influencing cells of the inner cell mass 
and its derivatives (Edwards and Hansis, 2005). 
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Figure 1.5. The schematic comparison between mouse (top) and human 
(bottom) embryonic implantation (Fitzgerald et al., 2008); Wang and Dey, 
2006). The position of blastocyst during attachment with maternal 
uterine wall is significantly different between mouse and human system. 
Between the mouse and human embryo there are significant differences in the 
blastocyst position during attachment to the maternal endometrial wall (Figure 1.5). 
In the mouse the mural trophectoderm makes the direct contact with the endometrial 
wall (Mehrotra, 1984) whereas in human it is the polar trophectoderm (Bai et al., 
2012; Roberts and Fisher, 2011). This is the beginning of extensive overt 
morphological differences between mouse and human early development, particularly 




1.2.2 Unique Characteristics and Functions of Human Placenta Development 
The trophoblast in these pre-placental stages transition through placentation to form 
the mature placental structure. As described by Mossman (1937), the placenta acts as 
a connection site for the mixture of maternal and fetal tissues and noted the degree of 
apposition may vary among species. Indeed, this mammalian-specific organ is 
considered to be the most morphological diverse organ in mammals (Carter and 
Enders, 2004). Classification systems have been developed to define this diversity. 
Morphologically, the placenta is generally classified into four types: Diffuse, Zonary, 
Cotyledonary, and Discoid (Leiser and Kaufmann, 1994). Boyd & Hamilton (1970) 
exquisitely report and validate the placenta in humans as a discoid type with a double-
disc shape. This morphological classification system invariably has exceptions within 
mammalian orders, for example most of the ruminant’s  placenta  is  cotyledonary, but 
that of the mouse deer is diffuse. A second classification system was established by 
Grosser in 1909, this was based on the number of layers of tissue between the fetal 
and maternal blood. The Grosser classification separates placenta into four types, 
Epitheliochorial (e.g. pig and horse), Syndesmochorial (e.g. ruminants), 
Endotheliochorial (e.g. carnivores), and Haemochorial (e.g. rodents, primates) 
(Amoroso, 1952). Some modifications have been made to the Grosser classification 
system since it was first developed. Enders (Enders, 1965) in a thorough comparative 
study, demonstrated that the haemochorial placental type is not limited to only one 
layer of tissue between fetal-maternal blood, for example rat and mouse have three 
layers (haemotrichorial), the rabbit has two layers (haemodichorial), and the human 
has only one layer (haemomonochorial). Thus the human placenta is a 
haemomonochorial villous organ where maternal blood comes into direct contact with 
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placental trophoblast cells and this facilitates an intimate connection between the 
developing embryo and its supply of maternal nutrients (Gude et al., 2004).   
As described above implantation and placentation in the human/primate is unique so 
common mammalian model systems, (e.g. rats, mice, or rabbits) are inappropriate for 
the study of human implantation and placentation (Lee and deMayo, 2004). 
Successful   implantation   is   regulated   by   complex   molecular   “cross-talk”   between  
hormonally primed uterus and the mature blastocyst (Enders, 2000). The period of 
uterine receptivity in human is relatively short, occurring around cycle days 20-24 of 
a 28 day menstrual cycle (Lessey, 2011). Characteristics of uterine receptivity include 
histologic changes, with the endometrium becoming more vascular and edematous, 
the endometrial glands have elevated secretory activity, and pinopodes develop on the 
luminal surface of the epithelium (Bergh and Navot, 1992). The underlying molecular 
mechanisms underlying these events are largely unknown. The physiological 
preparation of the endometrium is regulated by cyclic secretion of estrogen (17β-
estradiol) and progesterone (Lessey et al., 1996; Zhang et al., 2013). In response to a 
receptive uterus, the implanting blastocyst will secrete chorionic gonadotrophin 
hormone for maintenance of the corpus luteum (CL) and, subsequently, continued 
support of pregnancy (Järvelä et al., 2008). Chorionic gonadotrophin is not present in 
the mouse genome, while it is essential in the human gestation{Kumar:1995tq}. 
Human blastocyst implantation takes place at approximately day 7-post fertilization 
(Vigano et al., 2003).  During   implantation,   the   “cross-talk”   between   the   uterus   and  
blastocyst involves various growth factors (EGF, VEGF), cytokines, (LIF, IL-10-18), 
and adhesion molecules (MUC, Integrins) (Lim et al., 2002; Salamonsen et al., 2000). 
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Leukemia Inhibitory Factor (LIF) is a small heavily glycosylated protein of 180 
amino acid residues highly conserved across mammals (Paiva et al., 2009). LIF 
initiates signal transduction by binding to the LIF receptor, these leads to 
heterodimerization between LIFR and the glycoprotein 130 (gp130) receptor (IL6STI). 
In the human endometrium, LIF is differentially expressed throughout the menstrual 
cycle where it is detected in the early secretory phase at both the mRNA and protein 
level with highest expression at the late secretory phase concentrated in the luminal 
and glandular epithelium during the implantation window (Aghajanova et al., 2003; 
Dimitriadis et al., 2000). Several clinical studies have reported a causal involvement 
of LIF and human infertility. For example women with previously unidentified 
infertility were detected to have rare point mutations in functionally crucial regions of 
LIF (Giess et al., 1999; Steck et al., 2004). A second study reported a statistically 
significant percentage of women with unidentified fertility have decreased levels of 
LIF during the window of implantation in comparison with a control group in uterine 
flushes (Laird et al., 1997). 
Another important cytokine in fetal-maternal communication is Interleukin-11 (IL-11), 
which is known to have anti-inflammatory activity with multiple biological actions 
(i.e. pleiotropic) such as mucosal protective effects (Keith et al., 1994; Sands, 1999). 
IL-11 binds its receptor (e.g. IL-11Ra) and subsequently heterodimerizes with 
glycoprotein 130 (gp130) in the same manner as LIF/LIFR complex (Dimitriadis et al., 
2000). IL-11 and IL-11Ra mRNA are constitutively expressed throughout the 
menstrual cycle with expression concentrated at the glandular epithelium (Cork et al., 
2002; Karpovich et al., 2003). 
 21 
The production of prostaglandin is essential during implantation (Jabbour and Sales, 
2004; Kang et al., 2005). Cyclooxygenase (COX) is an important regulatory molecule 
in prostaglandin production during implantation as it controls cytokine release, cell 
growth and differentiation and vascular responses (Kelly et al., 2001). COX is a rate-
limiting enzyme that converts arachidonic acid to prostaglandin H2 and exists in two 
isoforms: constitutive (COX-1) and inducible (COX-2) and has a role in the (Marions 
and Danielsson, 1999). In the endometrium, COX-1 is constitutively active and 
necessary for routine cellular functions, its expression decreases in response to 
progesterone and estradiol-17b during the mid-luteal phase of the menstrual cycle in 
anticipation of implantation (Smith and Dewitt, 1996). COX-2 production is not 
affected by steroid hormones and its expression is restricted to the site of implantation 
and dependent on the presence of a implanting blastocyst (Masferrer et al., 1995). The 
altered expression of COX-2 has been reported to cause impaired fertility and is also 
associated with various disorders such as endometriosis (Chishima et al., 2002; Ota et 
al., 2001) and endometrial adenocarcinomas (Uotila et al., 2002). 
Another reported cytokine present during implantation is Granulocyte Macrophage 
Colony Stimulating Factors (GM-CSF). This is a hematopoietic cytokine with well-
studied effects on the proliferation, survival, and differentiation of myeloid leukocytes 
and their precursors. GM-CSF has an important role in the functional activation of 
mature monocyte/macrophages, granulocytes, and dendritic cells, which also promote 
various inflammatory and immune activities, for example, phagocytosis and 
cytotoxicity, chemotaxis and adhesion, and also antigen processing and presentation 
(Gasson, 1991). Based on these characteristics, GM-CSF is viewed as an essential 
regulator of host response and defense to foreign injury, which possibly contributes to 
the pathophysiology of malignancy, infection, autoimmune, and inflammatory 
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diseases (Hamilton and Anderson, 2004). For decades, hematopoietic colony 
stimulating activity has been reported to be significant in the uterine and placental 
tissues (Burgess et al., 1977; Giacomini et al., 1995)), especially in the luminal and 
glandular epithelial cells of the endometrium (Zhao and Chegini, 1999). GM-CSF was 
recognized as a key component of this CSF bioactivity (Loke et al., 1992; Wegmann, 
1988). Upon embryo implantation, GM-CSF affects the network of cytokines and 
growth factors that regulate the morphological and functional development of the 
placenta (Bowen et al., 2002). These signaling factors tightly regulate the series of 
events affecting cytotrophoblast cell proliferation, invasion of maternal decidual 
tissues and uterine vessels, and terminal differentiation to generate 
syncytiotrophoblast cells (Morrish et al., 1998). GM-CSF null mutant mice exhibit a 
subfertility phenotype suggesting that inadequacy in this cytokine could result in 
disorders such as fetal growth restriction and pre-eclampsia caused by deficiency in 
placental development and function (Bulmer, 1992; Conrad and Benyo, 1997).  
The formation of the placenta begins upon implantation, after the blastocyst hatches 
from the zona pellucida and attaches to the maternal uterine wall (Aplin, 2000). The 
early stages in placenta development are referred to as pre-lacunar, lacunar, and 
villous stages (Huppertz, 2008). It has been reported that any alteration or failure in 
blastocyst rotation during pre-lacunar period results in abnormalities of placenta 
insertion into the chorionic plate (McLennan, 1968). At the moment of blastocyst 
attachment to the uterine epithelium, the polar trophoblast will further differentiate by 
fusion of single nucleated trophoblast to generate multinucleated syncytiotrophoblast. 
This syncytiotrophoblast exhibits invasive properties and, position at the leading edge, 
mediates the blastocyst’s penetration into the endometrial lining (Boyd and Hamilton, 
1960). It should be noted that, outside of using human embryos themselves in in vitro 
 23 
models of implantation, there is no known model to study these very early stages of 
embryonic development. Studies in vitro using human blastocysts have been 
performed to investigate interactions between the blastocyst and a monolayer of 
endometrial cells (Bentin-Ley and Lopata, 2000); unfortunately, fusion and further 
penetration was not observed in this study (Figure 1.6a). A rare image of an in vivo 
implanting rhesus monkey blastocyst was described by Heuser and Streeter (Heuser 
and Streeter, 1941). In this they describe the existence of nuclei aggregates 
(multinucleated compartment) within the blastocyst at the interface of the trophoblast 
and endometrial wall (Figure 1.6b). Although, the early invasive syncytiotrophoblast 
was unfortunately misinterpreted by previous investigator as uterine cytolysis, Enders, 
et al. (Enders et al., 1983) managed to replicate the experiment using the pre-lacunar 
and lacunar stage as guidelines to prove that the early invasive syncytiotrophoblast 
cells are indeed a result of fusion of cells from the polar trophectoderm. Evidence 
included an invading bridge of syncytiotrophoblast without apparent membrane 
destruction or internalization of the maternal junction.  
                             
Figure 1.6. in vitro human blastocyst implantation (left) and in vivo 
macaque blastocyst implantation (right). The in vitro human blastocyst 
picture was obtained from Bentin-Ley and Lopata (2000), and shows 
blastocyst attachment to the pinopodes on a endometrial cell monolayer. 
The in vivo rhesus monkey blastocyst section was obtained from 
Heuser & Streeter (1941) that is available on http://www.ehd.org/virtual-
human-embryo/figure.php?stage=4&figure=21. 
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Over the next several days the embryo completely embeds into the decidual stroma 
with the syncytiotrophoblast forming a blanket covering the conceptus entirely 
(Hamilton et al., 1943). The mononuclei trophoblast or cytotrophoblast underlies the 
invasive syncytiotrophoblast on the embryonic side and is entirely isolated from 
maternal contact. The cytotrophoblast cells are rapidly proliferating and will continue 
to fuse and contribute to the expanding invasive syncytiotrophoblast (Hertig & Rock 
1945). Since currently it is impossible to obtain human samples to study the events 
during this early period of implantation, most of these observations are based on 
morphological assessment of the classic Carnegie collection of tissue sections from 
human embryos of early post-implantation. The expansion of the early invasive 
syncytiotrophoblast at the uterine stroma can be observed in the one of the specimens 
aged 7 days post-conception (Figure 1.7).  
                    
Figure 1.7. A tissue section of a human blastocyst implanting into the 
maternal uterine wall. This is at Carnegie stage 5A estimated to be 2 
days post-implantation. The figure was first published by Hertig & Rock 
(1945) and was modified and digitally obtained from 
http://www.ehd.org/virtual-human-embryo/figure.php?stage=5a-
1&figure=3. 
The lacunar stage begins approximately eight days post-conception when fluid-filled 




larger lacunae (Enders, 1989). After lacunae formation, the foundation zones of the 
placenta can be divided into three: the embryo-oriented chorionic plate, the primitive 
basal plate facing the endometrium, and the group of lacunae essential for formation 
of the intervillous space and villous trees (Hertig et al., 1956). At lacunar period, the 
lacunae of the syncytiotrophoblast is yet completed and an extremely low level of 
maternal erythrocytes within the syncytial lacunae is found, which is might because of 
the penetration of invading syncytiotrophoblast into the intersitium of the 
endometrium and later encountering the endometrial maternal capillaries and the 
superficial venous plexus (Carter, 1997). The placenta proper has yet to be completely 
formed at this stage thus there remains little contact with maternal blood.  
The nutritional requirements of the developing embryo are maintained through supply 
from maternal uterine glands via histiotrophic nutrition and, without maternal blood, 
in low oxygen levels. The earlier assumption was that the maternal blood was 
established within the placenta immediately after implantation by trophoblast invasion 
into the maternal endometrial blood vessels (Larsen, 1997). However, this assumption 
was found to be incorrect as subsequent observations on maternal circulation detected 
through anatomical and ultrasound methods identified that maternal blood circulation 
only occurs much later into pregnancy at approximately 12 weeks of gestation (Hustin 
and Schaaps, 1987). Subsequent work using Doppler echography, molecular 
approaches, and antioxidant enzymatic reaction measurements, confirmed that indeed 
maternal blood circulation is extremely limited to absent during the first trimester of 
pregnancy (Jaffe et al., 1995; Jauniaux et al., 1995; Jauniaux et al., 2010). While 
anatomically fully established, the placenta maintains this oxygen-restricted 
environment  as  a  result  of  “cytotrophoblast  plugs”  at  junction  between  the  opening  of  
the uteroplacental arteries and the intervillous space which prevents maternal blood 
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flow into the intervillous space. These plugs are loosened at the end of first trimester 
(Burton et al., 1999; Hustin and Schaaps, 1987). It is proposed that this lack of 
maternal blood flow into the placenta is to prevent elevated oxygen levels and their 
associated reactive oxygen species (ROS) which might affect the crucial stages of 
fetal organogenesis that occur in first trimester (Jauniaux, 2001). It was reported that 
several pregnancy disorders were associated with abnormalities in oxygen level 
during early first trimester, which might be caused by the presence of ROS that 
induces the DNA damage during embryo development (Eriksson, 1999; Jaffe et al., 
1995). 
                           
Figure 1.8. The Barnes embryo tissue section. The embryo aged 10½ 
days post conception, is estimated to be approximately 3 days post-
implantation (Hamilton et al., 1943).  
Prior to the establishment of maternal uteroplacental circulation (i.e. haemotrophic 
nutrition) the maternal uterine gland is an important source of nutrients. It is from 
here that the majority of nutrition (i.e. histiotrophic nutrition) is derived to support 
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development of the embryo during the first trimester (Burton et al., 2001). Maternal 
uterine gland secretions are sustained and prolonged by the corpus luteum and its 
hCG-induced continued production of progesterone (Wooding & Flint, 1994). In 
support of histiotrophic nutrition Schaaps and Hustin (Schaaps and Hustin, 1988) 
showed directly by hysteroscope that the intervillous space (IVS) is filled with a 
colourless fluid prior to 10 weeks of gestation. and the further validation was made to 
confirm the involvement of maternal uterine glands in providing the nutrients for 
embryo development during this phase (Burton et al., 2002). The major nutrients from 
the uterine gland include glycogen (glycodelin A), amino acids and/or protein (MUC-
1), and lipids (Beier-Hellwig et al., 1989; Bell, 1988). These nutrients are taken up by 
the syncytiotrophoblast through phagocytosis and delivered towards the developing 
fetus through energy obtained by anaerobic glycolysis (Burton et al., 2002; New, 
1978). The direct role of the syncytiotrophoblast in facilitating the histiotrophic 
nutrient transfer from the maternal uterine glands can be observed from one of the 
Carneige embryos, referred to as the Barnes embryo and estimated to be 12 days post-
conception or 5 days post-implantation (Figure 1.8). From this section it can be seen 
that the multinucleated syncytiotrophoblast cells are in direct contact and aligning the 
maternal uterine glands (Hamilton et al., 1943). Besides nutrition, maternal uterine 
glands are an important source of cytokines and growth factors such as uteroglobin 
(Müller-Schöttle et al., 1999), Tumor Necrosis Factor-α (von Wolff et al., 1999), 
Epidermal Growth Factor (Ladines-Llave et al., 1991; Mühlhauser et al., 1993), 
Keratinocyte Growth Factor, Vascular Endothelial Growth Factor, and Colony 
Stimulating Factor (Hill, 2001). These cytokines and growth factors are then in a 
position to affect trophoblast development, differentiation, and migration in the 
establishment of the placenta (Hempstock et al., 2004; Lala et al., 1998).   
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The implantation process is considered complete at approximately 12 days post-
conception, when the whole embryo and its surroundings are fully embedded in the 
uterine wall. The syncytiotrophoblast at this stage shows a morphological gradient, 
being thicker with better lacunae formation at the embryonic pole or point of 
implantation and thinner with less-developed lacunae at the apolar end of the 
blastocyst. During this period, growth in both cytotrophoblast and extraembryonic 
mesoderm form the chorion compartment (Enders and King, 1988; Luckett, 1978). 
Cytotrophoblast cells also start to rapidly proliferate and begin to pass through the 
syncytiotrophoblast layer making their first contact with maternal tissue. These cells 
are destined to become the invasive extravillous trophoblast that invade through the 
primitive basal plate, forming trophoblast columns, and reaching the capillaries 
between the uterine glands. A subset of extravillous trophoblast will further invade 
the wall of the uterine spiral arteries at the intersitium and finally enter the blood 
vessel lumen (Pijnenborg, 1990). This invasion by extravillous trophoblast 
(endovascular trophoblast) involves the replacement of uterine endothelial cells with 
fetal trophoblast and result in arterial remodeling (Kaufmann et al., 2003). At the 
same time, the highly proliferative extravillous cytotrophoblast will plug the uterine 
arteries to prevent blood flow into the developing placenta (Burton et al., 1999; Red-
Horse et al., 2004). 
The villous stage begins with the branching of syncytiotrophoblasts (also referred to 
as syncytial sprouts) containing cytotrophoblast cores. These structures (i.e. primary 
villi) face into the lacunae or IVS (Jackson et al., 1992). Subsequently, the 
extraembryonic mesodermal cells follow the cytotrophoblasts and penetrate into the 
syncytial-IVS compartment but stop soon enough to provide space for the 
cytotrophoblast. This structure is called the cytotrophoblast column and acts as a 
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proliferating source of extravillous cytotrophoblast which will disappear with 
gestational age. The penetration of mesodermal cells into the primary villi structure 
will transform them into secondary villi (Dempsey, 1972). Finally, the tertiary villi 
structure is established from the formation of independent placental blood vessels by 
differentiation of haematopoietic progenitors into placenta blood cells and 
combination with endothelial cells (Demir et al., 1989). The villous or non-migratory 
cytotrophoblast will fuse together to form the non-invasive syncytiotrophoblast and 
overlay the villi surface for facilitating the nutrient transfer from the maternal blood 
later on (Boyd & Hamilton, 1970). Only at the beginning of second trimester, the 
cytotrophoblast plug loosen and allows the flow of maternal blood into the IVS and 
the switch from histiotrophic nutrition to haemotrophic nutrition takes place during 
this period (Jauniaux et al., 2010; Rodesch et al., 1992). 
1.2.3. Trophoblast-derived Cell Types in The Placenta 
There are a number cell types within the trophoblast lineage all of which contribute to 
the formation of placenta. The stem cell of the placenta is the cytotrophoblast and this 
can differentiate to either the villous or non-villous pathway (Douglas et al., 2009). 
The presumption is that a cytotrophoblast first appears in the trophectoderm of the 
blastocyst. There has yet to be any success in deriving a self-renewing human 
cytotrophoblast in vitro, making the molecular study of its control and differentiation 
elusive. The in vivo cytotrophoblast is highly proliferative and differentiates into 
early-multinucleated syncytiotrophoblast called primitive syncytium, forming within 
the   polar   trophectoderm.   This   early   syncytiotrophoblast   will   mediate   the   embryo’s  
invasion into the maternal uterine wall (Boyd and Hamilton, 1960; Hamilton et al., 
1943). Due to its inaccessibility and its primate-specificity, information regarding this 
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early invasive syncytiotrophoblast is limited to only morphological data (Boyd and 
Hamilton, 1960; Enders et al., 1983). Behind this advancing primitive syncytium is 
the highly proliferative cytotrophoblast which will, for a short time, continue to give 
rise to primitive syncytium but also to either one of two major trophoblast lineage 
pathways, one contributing to the placental villous structures and the other to the 
extravillous trophoblast cells destined to invade the maternal blood vessels (Douglas 
et al., 2009).  
In the villous pathway the cytotrophoblast will both continue to self-renew as well as 
fuse to form the terminally differentiated and non-invasive villous syncytiotrophoblast 
(James et al., 2005). This process is continuous throughout pregnancy as the villous 
syncytiotrophoblast needs continuous replenishing. The villous syncytiotrophoblast 
then overlays the placenta villous tree surface and is directly responsible for 
mediating histiotrophic and hemiotrophic uptake of nutrition (Aplin, 2010; Red-Horse 
et al., 2004). To fulfill this transport function, various molecular transporters are 
expressed on the basal (fetal side) and apical (maternal side) surface of the villous 
syncytiotrophoblast (Kulanthaivel et al., 1992; Riquelme, 2011). 
The extravillous pathway also initiates from the cytotrophoblast cells. Proliferating 
cytotrophoblast will breach through the villous tree and invade the maternal spiral 
arteries, these cells subsequently differentiate into highly invasive extravillous 
cytotrophoblast. The extravillous cytotrophoblast will keep invading to reach the 
myometrium and differentiate into endovascular trophoblast tasked in artery 
remodeling by replacing the maternal blood vessel endothelial cells with fetal 
trophoblast (Kaufmann et al., 2003). Finally, this complex orchestration of various 
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trophoblast cell types will form the definitive structure of the placenta to support fetal 
development throughout pregnancy (Huppertz, 2008). 
1.2.4. Human Embryonic Stem Cells as a Tool to Study the Trophoblast Lineage 
Human embryonic stem cells (hESC) are pluripotent stem cells isolated from ICM of 
the blastocyst and have the ability of hESC to spontaneously differentiate towards the 
trophoblast lineage (Thomson et al, 1998). BMP4 has long been known as an inducer 
(Xu et al., 2002). That said, BMP signaling is known to play a role in hESC 
differentiation into other lineages as well, including mesoderm (Zhang et al., 2008), 
extraembryonic endoderm (Pera and Trounson, 2004), and hematopoietic cells 
(Chadwick et al., 2003). In terms of pluripotency maintenance and differentiation, 
BMP signaling shows opposing effects between human and mouse embryonic stem 
cells as in the mouse BMP4 aids in maintaining the undifferentiated state (Hall et al., 
2009). It was also reported that the induction of BMP signaling in combination with 
ACTIVIN/NODAL signaling pathway is essential for trophoblast differentiation (Wu 
et al., 2008).. 
Another essential signaling pathway in hESC differentiation towards trophoblast 
lineage is Transforming Growth Factor-β (TGF-β) pathway. This signaling pathway is 
known for its role in embryonic development and patterning also epithelial-to-
mesenchymal transformation (Gordon and Blobe, 2008). The TGF-β signaling 
pathway can be separated into two branches, the Activin/Nodal pathway branch and 
BMP branch (Zi et al., 2012). The first branch is induced by multiple ligands, 
including Activin, Nodal, and TGFβI, which then binds to the type II receptor and 
results in the type I receptor recruitment. The phosphorylation of the type I receptor 
intracellular domain creates a binding site for transcription factors SMAD2 and 
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SMAD3, which upon binding the receptor, are phosphorylated by the type I receptor. 
The phosphorylated SMAD2/3 then associate with SMAD4 and enter the nucleus and 
directly regulate gene expression (Feng and Derynck, 2005). The similar activation 
mechanism also applies to BMP branch. Upon BMP ligand binding, the 
phosphorylation of type I receptor by type II receptor takes place and results in 
SMAD1/5/8 intracellullar binding and phosphorylation by the type II receptor. The 
phosphorylated SMAD1/5/8 then associates with SMAD4 and enter the nucleus to 
directly regulate gene expression (Shi and Massagué, 2003). Interestingly, 
Activin/Nodal signaling is important in maintaining hESC in the pluripotency state as 
the pluripotency factor Nanog is a direct positive target of SMAD2/3 (Xu et al., 2008). 
It was also reported that Activin A, one of the Activin/Nodal signaling ligands, 
managed to restore the expression of Lefty-A, Lefty-B, and Nodal, which balances the 
BMP inhibition of Activin/Nodal signaling. Moreover, Activin A was observed to 
inhibit CG-α and CG-β, both of which were induced by BMP4. Therefore, the 
inhibition of Activin/Nodal signaling in hESC results in BMP signaling up-regulation 
followed by differentiation into trophectoderm (Wu et al., 2008).  
Another signaling pathway that affects the hESC differentiation into trophoblast 
lineage is the Fibroblast Growth Factor (FGF) signaling pathway. The FGF pathway 
plays many roles in embryonic development, patterning, the regulation of cell growth, 
proliferation, and motility (Dorey and Amaya, 2010). The activation of the FGF 
pathway is mediated by binding FGF ligand to the FGF receptor and results in a 2:2:2 
combination of FGF:FGFR:Heparan Sulfate Proteoglycans (HSPGs) on the cell 
membrane. The receptor dimerization causes trans-phosphorylation of tyrosine 
residues in the intracellular domains of FGFRs through their own tyrosine kinase 
domains. The phosphorylated tyrosines of FGFRs recruit and activate the GRB2/SOS 
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complex. SOS then activates RAS and initiates the MAPK cascade, which leads to the 
activation of extracellular-signal related kinases (ERKs) (Vanderkuur et al., 1997). 
The activities of various types of proteins are known to be regulated by activated 
ERK1/2. One example is the phosphorylation of the SMAD1 linker region which 
leads to its destabilization and thus inhibits the BMP signaling (Lanner and Rossant, 
2010). FGF2 is known to be important in maintaining hESC self-renewal through 
FGF receptor type 2 (FGFR2) (Eiselleova et al., 2009). It was reported that chemical 
inhibition of FGF receptors or downstream ERK signaling in hESC results in the up-
regulation of trophectoderm markers, such as CDX1/2 and gonadotrophin-a/b (Li et 
al., 2007) as well as primitive endoderm markers such as SOX7 (D’Amour   et   al.,  
2005). 
1.3. Trophoblast Lineage Derived from Human Embryonic Stem Cells 
Since, there is little known regarding early implantation and placentation in humans, 
many attempts involving choriocarcinoma cell lines, animal models, and clinical 
human placental explants, have been used to decipher the complex and unexplored 
human placentation during the early implantation period. However, despite this, there 
is still debate whether the results are actually comparable to what happens in vivo. 
The capacity of human pluripotent stem cells to differentiate into apparently all types 
of cells in the human body and into extra-embryonic structures including the 
trophoblast lineage makes hESC the most promising solution to investigate events in 
human early development. 
1.3.1. Human Embryonic Stem Cells 
The embryonic stem cell (ESC) is derived from the Inner Cell Mass (ICM) of the 
blastocyst (Martin, 1981). There are two basic characteristics of ESC that differentiate 
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this type of cell from others. First, ESC are pluripotent meaning they have the 
capacity to give rise to all types of cells in the three germ layers (ectoderm, mesoderm, 
and endoderm) when cultured under appropriate physiological conditions. They also 
have the capability to divide indefinitely in culture a processed termed self-renewal 
(Evans and Kaufmann, 1981). The concept of a pluripotent stem cell originated from 
studies in teratocarcinomas in mouse. These are gonad tumors that consist of a 
remarkable array of somatic tissues connected together in a jumbled fashion. The 
study on teratocarcinomas established their origins from germ cells in mice and 
generated the concept of a stem cell (embryonal carcinoma or EC) that give rise to 
multiple types of tissue in the tumours (Kleinsmith and Pierce, 1946; Stevens, 1980). 
Realizing the limitation of EC cells with their chromosomal abnormalities and 
limitations in generating multiple tissues, encouraged the isolation of pluripotent stem 
cells directly from blastocyst rather than teratocarcinomas based on the idea that 
teratocarcinomas can also be induced by blastocyst grafting to ectopic sites (Evans 
and Kaufmann, 1981; Martin, 1981). Finally, after successfully isolating embryonic 
stem cells from rhesus monkey and marmoset blastocysts (Thomson et al., 1995; 
1996), James Thomson and co-workers managed to isolate embryonic stem cells from 
IVF donated human blastocysts and established several ESC lines in vitro. The hESCs 
were isolated from the blastocyst by removing the trophectoderm, which was thought 
to be an inhibitor to ES cell establishment, and then were cultured on irradiated mouse 
embryonic fibroblast cells as a feeder layer (Thomson et al., 1998). hESC derivations 
were replicated by Reubinoff, et al. (2000), using four donated human blastocyst they 
managed to derive two hESC lines. They also performed somatic differentiation from 
hESC into neural progenitor-like cells by limiting stem cell renewal without inducing 
cell death and also inhibiting spontaneous differentiation into extraembryonic tissue 
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(Reubinoff et al., 2000). In order to maintain a long-term culture, MEFs were used as 
a feeder layer to support the undifferentiated state of hESC during their propagation 
(Bosma et al., 1983; Reubinoff et al., 2000). Various human-derived cell types have 
been used and established as a feeder layer to achieve xeno-free hESC culture systems, 
including fetal foreskin, muscle (Amit et al., 2003), fallopian tube epithelium (Bongso 
et al., 1994), amniotic epithelium (Miyamoto et al., 2004), and bone marrow (Cheng 
et al., 2003). hESC can also now be propagated under feeder-free conditions in the 
presence of extracellular matrices, for example fibronectin, laminin, or Matrigel, the 
later a mixture of various extracellular matrices (Richards et al., 2002; Xu et al., 
2001). Nonetheless, in the feeder-free culture, culture media conditioned with MEF 
feeder layer supplemented with basic Fibroblast Growth Factor (bFGF) are used to 
maintain the undifferentiated state of hESC (Van Hoof et al., 2008; Xu et al., 2001). 
The hESC has typical features of high nucleus to cytoplasm ratio with prominent 
nucleoli and commonly grow in a highly compact colony and maintaining a defined 
border at the colony periphery (Thomson et al., 2008). The molecular features of 
hESC are characterized by expression of various surface markers, including stage-
specific embryonic antigen-3 (SSEA-3), SSEA-4, TRA-1-60, TRA-1-80 (Carpenter et 
al., 2003; Draper et al., 2002), the transcription factors Oct3/4 (Chambers et al., 2003) 
and Nanog, and the enzyme alkaline phosphatase (Nichols et al., 1998). On the other 
hand, the hESC is absence for negative markers such as SSEA-1 (Carpenter, Rosler, 
and Rao, 2003; Chambers et al., 2003; Draper et al., 2004; Heins et al., 2004; Nichols 
et al., 1998). Besides the capability to derive various cell types from all three germ 
layers, hESC also have the capability to derive extraembryonic lineage, such as 
trophectoderm by spontaneous differentiation in culture (Thomson et al., 1998).  
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1.3.2. Human Embryonic Stem Cell-derived Trophoblast 
The ability of hESC to generate the trophoblast lineage was observed in the original 
derivation reported by Thomson and co-workers (Thomson et al., 1998). When hESC 
are grown to confluence and pile up in the culture dish, they differentiate 
spontaneously, even in the presence of a feeder layer. Different from the maintenance 
of mouse ESCs, which are maintained by BMP4 and LIF (Hall et al., 2009), the 
addition of bFGF was proven to give the best result in maintaining the 
undifferentiated state of hESC (Amit et al., 2000). The BMP signaling in the 
trophoblast was first described by Xu, et al. (2002) by using various BMP family 
members, including BMP4, BMP2, BMP7, and Growth and Differentiation Factor 5 
(GDF5), in the conditioned media supplemented with bFGF, which then generated 
flattened and enlarged cells with reduced proliferation rate. Generally, there are two 
ways to derive the trophoblast lineage from hESC, through the formation of embryoid 
bodies (EB) in three-dimensional culture and BMP4 induction in two-dimensional 
monolayer culture. The first method was described by (Gerami-Naini et al., 2004), 
and is done by collecting spontaneously differentiating trophoblast from EBs, 
embryo-like structures generated from disaggregated hESC cultured in media lacking 
growth factors used to support pluripotency and later then is sorted out based on the 
hCG production (Harun et al., 2006). An alternative way and more of a directed 
differentiation to trophoblast can be performed in two-dimensional cultures, where 
hESC are cultured on Matrigel-coated plates in the presence of growth factors from 
BMP family, especially BMP4, the most effective compound tested (Xu et al., 2002). 
Addition of BMP4 (10-100 ng/ml) leads to the appearance of epithelial-like cells 
starting at the periphery of the colonies and moving towards the center at a 
concentration-dependent rate (Liu et al., 2004). A microarray analysis of BMP4-
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treated hESC-differentiated trophoblast indicated an up-regulation of transcription 
factors that are specific to the trophoblast lineage, such as ID2, GATA2, GATA3 and 
MSX2 (Babaie et al., 2007; Hay et al., 2004). From various experiments to uniformly 
derive trophoblast lineage from hESC, it was reported that to direct the differentiation 
specifically to trophoblast rather than to other lineages it was important to inhibit 
bFGF, an essential component in maintaining hESC pluripotency, in the BMP4 
induced differentiation method (Amit et al., 2000; Ezashi et al., 2012; Vallier et al., 
2005). If BMP4 is combined with bFGF in the culture, it causes alteration in the cells 
morphological transition, the colonies start to form various mesoderm and endoderm 
derivatives, in addition to trophoblast (Bernardo et al., 2011; Das et al., 2007; 
Drukker et al., 2012). This outcome is probably caused by bFGF signaling through 
the MEK/ERK pathway, thus retaining the expression of NANOG (Greber et al., 
2010; Yu et al., 2011). To conclude, by supporting the BMP signaling (with BMP4 
addition) and minimizing the MEK/ERK pathway, for example FGF signaling 
inhibition, the optimal differentiation of hESC towards trophoblast lineage can be 
achieved.  
1.4. The Syncytiotrophoblast 
The Syncytiotrophoblast is the morphologically most distinguished cell type 
belonging to trophoblast lineage. It is a terminally differentiated continuous layer 
containing multiple nuclei with no defined lateral cell borders (Fox and Kharkongor, 
1970; Palmer et al., 1997). The formation of the syncytiotrophoblast involves the 
fusion of mononuclei cytotrophoblasts and does not exhibit any proliferative activity 
in any of its nuclei, which also shows a reduced rate of transcriptional activity (Chan 
et al., 1999; Kar et al., 2007). Therefore, the maintenance of a continuous syncytial 
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layer is solely dependent on the fusion of cytotrophoblast throughout gestation (Mori 
et al., 2007). The cell cycle interruption or suppression of cytotrophoblast 
proliferation by inhibition of DNA synthesis and replication were reported as the 
factors that trigger the cytotrophoblast differentiation into syncytiotrophoblast 
(Crocker et al., 2007; Genbacev et al., 2000). The cytoplasm of syncytiotrophoblast 
contains various types and numbers of organelles, pinocytotic vesicles, dense bodies, 
and ribosomes (Jones and Fox, 1991). The nucleus from the cytotrophoblast that 
incorporates into the syncytiotrophoblast by fusion undergoes morphological changes 
into large and ovoid shape (Mayhew et al., 1999; Nelson, 1996). The nucleus is 
originally rich in euchromatin further develops late apoptotic features by displaying 
an annular chromatin aggregation in parts of the syncytiotrophoblast, these are called 
syncytial knots and are later shed from the apical syncytiotrophoblast into the 
maternal circulation (Cantle et al., 1987; Huppertz et al., 1988; Jones and Fox, 1977).  
1.4.1. Types of Human Syncytiotrophoblast 
The existence of various trophoblast cell types has been noted as crucial in 
maintaining proper embryo growth throughout pregnancy. There are at least two types 
of known syncytiotrophoblast (Boyd and Hamilton, 1960). Firstly, the 
syncytiotrophoblast that contributes to the villous tree within the uterine epithelium, 
called villous syncytiotrophoblast (Castellucci et al., 1990). It overlays the surface of 
the villous separating the fetal and maternal blood circulation (Huppertz et al., 2006). 
The villous syncytiotrophoblast has an important role in facilitating the nutrient 
transfer from maternal blood towards the fetus and also facilitates the waste and gas 
exchange from the fetus (Shennan et al., 1986; Stulc, 1997). Besides facilitating the 
nutrient transfer, the villous syncytiotrophoblast also acts as an endocrine organ to 
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produce various growth factors and hormones that regulate fetal growth and 
development (Nelson, 1996; Torry et al., 1999), for example Insulin-like Growth 
Factor (IGF) and Vascular Endothelial Growth Factor (VEGF) (Crocker et al., 2011). 
The villous cytotrophoblast will continuously fuse together to form the villous 
syncytiotrophoblast and after 48 hours, the existing syncytiotrophoblast will undergo 
apoptosis and be shed into maternal circulation (James et al., 2005). This cell also 
secretes chorionic gonadotrophin hormone (hCG) (Shi et al., 1993; Yang et al., 2003), 
which is an important hormone in pregnancy that has a role in maintaining the corpus 
luteum and progesterone levels (Järvelä, et al., 2008). The hCG has two different 
subunits, α (CGA) and β (CGB) that is especially restricted to villous 
syncytiotrophoblast (Cocquebert et al., 2012). 
The syncytiotrophoblast that exists during the early period of embryonic implantation 
and originates from the polar or embryonic site of trophectoderm, which is called the 
primitive syncytium (Hamilton et al., 1943). Due to its restricted and transient 
developmental position, it is ethically and technically impossible to be isolated from 
an in vivo source, thus the knowledge about this early syncytiotrophoblast remains 
unexplored. Different from the well-studied villous syncytiotrophoblast, early 
primitive syncytiotrophoblast has invasive characteristic in accordance with its 
possible role to mediate embryo invasion into the maternal uterine wall (Enders, 
2000). The invasive syncytiotrophoblast is the first fetal tissue that is in direct contact 
with the maternal uterine epithelium (Staun-Ram and Shalev, 2005). Apart from its 
role in invading the maternal uterine wall, the invasive syncytiotrophoblast also has a 
role in facilitating nutrient and molecule transport to the developing conceptus during 
the histiotrophic period before maternal circulation is established (Burton et al., 2001; 
2002). However, the molecular background, mechanism of invasion, and the 
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similarity of fusion mechanisms of the invasive syncytiotrophoblast with its other 
infamous villous syncytiotrophoblast still remain elusive.  
1.4.2. The Invasive Syncytiotrophoblast at Implantation 
As described earlier, between two existing types of syncytiotrophoblast, there is one 
that presents during early embryonic implantation and was suggested to invade the 
uterine wall. Because of the period where this invasive syncytiotrophoblast plays its 
role is completely inaccessible, the existence of invasive syncytiotrophoblast has been 
doubted. However, by referring to the classic Carneige collection of human embryo 
sections from various stages of implantation, as early as 2 to 3 days post-implantation 
(Hertig & Rock, 1945). The Carneige embryo #8020 from around 7 days post-
conception shows the early implanted embryo into the maternal uterine wall and the 
presence of syncytiotrophoblast at direct contact with maternal side varying from thin 
layer at abembryonic pole to thick layer at embryonic pole or point of implantation 
(Hertig & Rock, 1949). From these sections of early human embryonic implantation, 
they give morphological evidence of multinucleated syncytiotrophoblast presence in 
vivo. Moreover, by assessing the invasive syncytiotrophoblast direct position with 
maternal side separating the remaining fetal tissues, it suggests the essential role of 
invasive syncytiotrophoblast to properly infiltrate the maternal side (Boyd and 
Hamilton, 1960). Besides the sections from Carneige collection, non-human primates, 
such as baboon, rhesus or macaque monkey, have been used as closest model to 
investigate various gestation events in human, including early implantation process, 
villous structure, the nature of the interhaemal barrier, and the pattern of circulation in 
the IVS (Blankenship and Enders, 2003; Carter, 2007; Fazleabas et al., 2007; Ramsey 
et al., 1976). Interestingly, from the macaque embryonic implantation study by 
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Heuser & Streeter (1941), they showed the formation of syncytiotrophoblast at the 
point of embryo attachment and the starting of invasion towards the maternal uterine 
epithelium. Unfortunately, aside from the morphology assessment of those samples, 
no known molecular investigation has been done to assess the details of the 
implantation.           
1.4.3. Suggested Molecular Signaling Pathways in The Syncytiotrophoblast 
The molecular signaling pathways governing the cytotrophoblast fusion in generating 
syncytiotrophoblast have been points of interest in human placentation. Several 
factors are suggested to be main players in fusion events of syncytiotrophoblast. The 
transcription factor Glial Cells Missing 1 (GCM-1) is commonly known as a main 
regulator of this event (Baczyk et al., 2009). GCM-1 is a placental-specific 
transcription factor that is commonly expressed in the cytotrophoblast and 
syncytiotrophoblast (Nait-Oumesmar et al., 2000), and is an upstream regulator of 
endogenous retroviral elements, including Syncytin-1 (ERVWE1) (Wich et al., 2009) 
and Syncytin-2 (HERVFRD1) (Liang et al., 2010). GCM-1 was up regulated in the 
hESC-differentiated trophoblast lineage upon 72 hours of differentiation (RNA-
sequencing   from   Dr.Robson’s   Lab),   while   it   was   not   activated   until   E8.5   days   in  
mouse system, which is much later (Schreiber et al., 2010). It was reported in 
choriocarcinoma cell line BeWo that the treatment with Forskolin stimulates the 
activation of cyclic AMP (cAMP), which induces the fusion of BeWo cells (Chang et 
al., 2011; Knerr et al., 2005). The cAMP activation leads to the stimulation of GCM-1 
via PKA signaling pathway, and GCM-1 subsequently activates genes responsible for 
mediating fusion, such as syncytin-1 and syncytin-2 (Yu et al., 2002). It was also 
reported that the transcription factors GATA-2 and GATA-3 might play a crucial role 
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in trophoblast differentiation (Home et al., 2009; Ni et al., 2004). As both of these 
transcription factors bind to the enhancer region of the syncytin gene, it was 
suggested that they may affect the cell specificity of the syncytin expression (Cheng 
and Handwerger, 2005). However, most of the forskolin-induced cAMP pathway 
syncytiotrophoblast formation experiments were conducted using choriocarcinoma 
cell lines, thus the details of its mechanism inducing cytotrophoblast fusion in vivo, 
especially in human, is still unclear.  
1.4.4. Mouse Syncytiotrophoblast in Relation to Human 
Even though human and mouse both exhibit haemochorial placentation, there are 
significant differences in placental development, including syncytiotrophoblast 
(Carter, 2007). The polar trophectoderm of the blastocyst mediates attachment and 
invasion of the human embryo (Bai et al., 2012), whereas it is the abembryonic or 
mural pole of blastocyst that mediates implantation in the mouse (Mehrotra, 1984). 
Mouse uterine decidualization is induced by the presence of the implantating embryo 
(Enders and Welch, 1993) whereas in human it is a spontaneous event occurring 
whether or not the embryo is present (Kliman, 2000). In correlation with blastocyst 
implantation, the human early invasive syncytiotrophoblast undergoes penetration and 
invasion to deeply embed the embryo into maternal uterine wall (Boyd and Hamilton, 
1960). However, in mouse, giant trophoblast mediates shallow invasion by engulfing 
(phagocytosis) the maternal epithelial, blood and decidual cells (Bevilacqua and 
Abrahamsohn, 1989), which resulting in the arteries as even the blood vessels of the 
decidua are lined by endothelium rather than trophoblast and attachment of embryo 
only on the surface of uterine wall and the growth happens in uterine cavity 
(Adamson et al., 2002; Redline and Lu, 1989). In terms of placentation, the human 
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placenta achieves its definitive structure as early as 21 days post fertilization 
(Benirschke & Kaufmann, 2000), but in mouse, the definitive structure is not apparent 
until reaching halfway through gestation (Rossant and Cross, 2001). During the early 
implantation in human, the cytotrophoblast will differentiate by fusion to contribute to 
the invading syncytiotrophoblast and the nutrient from maternal uterine gland will be 
transported by early syncytiotrophoblast to the embryo (Burton et al., 2001; 2007; 
Hempstock et al., 2004). Later, the cytotrophoblast will differentiate into either one of 
two pathways, villous and extravillous cytotrophoblast (James et al., 2005). The 
villous cytotrophoblast then will fuse to generate villous syncytiotrophoblast that 
overlays the villous tree to obtain nutrients from maternal blood and separating fetal 
and maternal blood (Aplin, 2010). On the other hand, the extravillous cytotrophoblast 
will invade the maternal blood vessel reaching the myometrium to establish the 
maternal blood circulation at the end of first trimester (Knöfler and Pollheimer, 2013).  
In contrast to human, the mouse trophoblast will first differentiate into two pathways, 
the polar trophectoderm differentiates into extraembryonic ectoderm and 
ectoplacental cone, while the mural trophectoderm in direct contact with maternal 
side forms the primary trophoblastic giant cells by endoreplicating their DNA 
(Rossant and Cross, 2001). The parietal endoderm then moves to the basal membrane 
of the trophoblast and deposits an extensive basement membrane separating from 
trophoblastic giant cells, which forms parietal yolk sac. This structure then absorbs 
the nutrients from the maternal blood through capillary channels sinuses in the 
decidual tissue (Müntener and Hsu, 1977). Later, the mesoderm will migrate to the 
visceral endoderm to form the visceral yolk sac and the nutrient exchanges take place 
in this vascularized zone (Downs, 2002). The mesoderm also forms allantoid 
mesenchyme to migrate towards the chorion at ectoplacental cone on gestation day 9-
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10 and establish the network of fetal blood vessel by invading the trophoblastic cells 
at the developing labyrinth (Steven & Morris, 1975). At around gestation days 12.5, 
the definitive chorioallantoic placenta is apparent with maternal decidual tissue is 
connected to trophoblastic giant cells and labyrinth zone develops from the 
trophoblast cells and its associated fetal blood vessels (Hernandez-Verdun, 1974). 
The labyrinth zone itself can be divided into two layers of syncytiotrophoblast in 
contact with fetal tissue and one cytotrophoblast layer in contact with maternal blood, 
which this structure is called haemotrichorial placentation (Enders, 1965). The 
maternal blood supply crosses the spongiotrophoblast layer via arterial sinuses that 
contain spongiotrophoblast cells (Adamson, 2002). The maternal blood further enters 
the labyrinth zone and bathes the fetal trophoblast to allow exchanges with fetal blood 
(Georgiades et al., 2002). Despite all the differences, some similarities exist between 
both species, for example an invasive pathway involving extravillous cytotrophoblast 
in humans and trophoblastic giant cells and glycogen cells in mice; and an nutrient 
exchange pathway involving the syncytiotrophoblast in mouse (labyrinth) and 
syncytiotrophoblast (villous) in human (Malassiné et al., 2003). Also, one of the 
important placental transcription factor GCM-1 that was reported to be essential in 
human and mouse; nevertheless, there is a difference in time of activation (Baczyk et 
al., 2009; Schreiber et al., 2000). 
 
1.5. Purposes and Hypothesis of Study 
In humans, early implantation and placentation have been one of the interesting topics 
in the field of early embryonic development. The uniqueness and complexity of the 
early implantation and placentation is yet explored due to the ethical concern with 
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technical impossibility. Also the unavailability of access to the sample of early human 
embryonic implantation makes this period largely unexplored. The earliest isolation 
of placental clinical sample would be end of first trimester, which the trophoblast 
population during that period might not be comparable to population from the early 
period of implantation and placentation. Various experimental studies have been tried 
to investigate, understand, and also to mimic the in vivo condition by using placental 
immortalized cell lines and animal models. The placental cancer cell line or 
choriocarcinoma, such as JEG-3 and BeWo, provides an easy option in vitro system 
to investigate the placentation events, but the difference in its nature of cell cycle 
might generate some bias in comparison with the in vivo actual counterpart. Based on 
the genes expression studies and the physiological studies of implantation and 
placentation, the uniqueness of human placentation makes the non-human primate as 
the closest option for animal model, while the significant differences in mice, which is 
mostly used as the common proxy to human system, make it becomes unsuitable in 
this particular events. Even the closest non-human primate model still exhibits several 
differences in placentation process, such as superficial implantation, limited 
decidualization, and dual insertion. Therefore, by utilizing the plasticity of human 
pluripotent stem cells (hESC/ hESC) in combination with the optimized standard 
hESC differentiation protocol towards trophoblast lineage, we hypothesized that 
hESC is a great and reliable model to investigate the early human placentation events, 
especially the generation of early trophoblast cell types.  
The time of existence and invasive characteristic of early syncytiotrophoblast creates 
a significant difference with the well-known villous syncytiotrophoblast that is widely 
studied. Due to the nature of invasive syncytiotrophoblast existence in vivo, very little 
is known about this trophoblast cell type. However, the role of invasive early 
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syncytiotrophoblast places it as a crucial player in human early embryonic 
implantation.  
Thus, the purpose of this study was to investigate and firstly derive a relatively pure 
population of early invasive syncytiotrophoblast from committed hESC-differentiated 
trophoblast lineage by screening various signaling molecules, for example cytokines 
or growth factors, in cell culture-based. The advanced screening technology (High 
Content Screening) platform was used to efficiently and vastly screen out the 
potential molecule(s) based on profound automated morphological assessments. 
Finally, the invasive syncytiotrophoblast culture was validated by investigating 














MATERIAL AND METHODS   
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2.1. Human embryonic stem cells culture. 
Human embryonic stem cell line H1 (WA01, Wicell) was maintained using defined 
supplemented mTeSR™1 media (StemCell Technologies), which is available 
commercially, in feeder-free culture system. Media was replaced daily and cells 
cultured up to 80% confluence prior to sub-culture at ratio of 1:12. Dispase (1 mg/ml, 
StemCell Technologies) was use to sub-culture the cells by incubation at 37oC for 
four minutes. In order to deactivate the dispase, basal media Dulbecco’s  Modified  
Eagle Media:Nutrient Mixture F/12 Media (DMEM-F/12 1:1; GIBCO, Life 
Technologies) was used to wash the cells before seeding. The cell pellet was then 
obtained by spinning down at 850 rpm for three minutes. The cells were resuspended 
in mTeSR media to evenly homogenize the cell clumps, and were seeded onto cell 
culture plates that were pre-coated with BD Matrigel™ Matrix Basement Membrane 
(BD Bioscience). The cells were then cultured at 37oC, 5% CO2, and 20% O2 for 
maintenance and expansion. 
For freezing down cells, cultures that reached 50-60% confluence were dissociated 
using the standard sub-culture method as described above. The cells then were 
pelleted by spinning down at 850 rpm for three minutes and resuspended in 1 ml of 
cryopreservation media mFreSR™ (StemCell Technologies) according to the standard 
protocol from the manufacture. The cells were dispensed into cryovials and kept in a 
“Mr.Frosty”   (Nalgene)   that  contains   isopropyl  alcohol   for  slow  freezing, and placed 
in -80oC overnight, before allocated to -150oC for long-term storage. For recovery of 
cells, the cryopreserved cells were rapidly thawed in pre-warmed DMEM-F/12 basal 
media. Cryopreservation media was subsequently removed by pelleting cells by 
centrifugation at 850rpm for three minutes. For seeding, the cell pellet was 
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resuspended in pre-warmed mTeSR media and seeded onto Matrigel pre-coated cell 
culture plate. The culture media is replaced with fresh media on the following day. 
Matrigel basement membrane was prepared a day prior to coat plates prior to 
subculture or cells. Matrigel solution and was diluted in ratio of 1:1 with ice-cold 
KnockOut™ Dulbecco’s   Modified   Eagle   Media (KO-DMEM; GIBCO, Life 
Technologies). The diluted Matrigel was then aliquoted into 1ml tubes and stored in -
20oC for stock. Prior to seeding new cells or subculturing, the aliquoted stock was 
slowly thawed at 4oC overnight. The stock Matrigel was then diluted in ice-cold 
DMEM-F/12  at  a  working  ratio  of  1:15.  A  “Thin  Coating” method was used to coat 
the cell culture plates by washing each well with a generous amount of Matrigel and 
dispensing adequate amounts to evenly cover the entire well surface. Afterwards, the 
cell culture plate is incubated at 37oC for one hour and the remaining Matrigel 
aspirated before seeding cells. 
2.2. Human embryonic stem cells differentiation towards trophoblast lineage 
The expanded hESC culture that had reached 80% confluencey was subcultured as 
described above onto the desired format of Matrigel-coated cell culture plates for 
differentiation. Cultures were grown in mTeSR media for 24 hours for recovery and 
settlement. On the following day, differentiation was initiated by aspirating the 
culture media and washing the cells with DMEM-F/12 two times in order to remove 
trace amounts of growth factors from the mTeSR media. The differentiation media 
that  is  referred  as  SB  onwards  was  adapted  from  the  Robson  lab’s  standard  protocol  
and consisted of 100 ng/ml recombinant human Bone Morphogenic Protein 4 
(rhBMP4; R&D Systems) and Fibroblast Growth Factor Receptor (FGFR) inhibitor, 
SU5402 (Calbiochem, Merck), mixed in DMEM-F/12 supplemented with 4 ng/uL of 
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recombinant human Basic Fibroblast Growth Factor (rhBFGF; GIBCO, Life 
Technologies), 20% KnockOut™ Serum Replacement (GIBCO, Life Technologies), 
1% MEM Non-Essential Amino Acids Solution (GIBCO, Life Technologies), and 1 
mM of L-Glutamine (GIBCO, Life Technologies) pre-mixed with 35 nM β-
mercaptoethanol (GIBCO, Life Technologies). The SB media was dispensed 
accordingly and replaced daily until the desired day of differentiation was reached. 
The culture was incubated in normal growth condition at 37oC with 5% CO2 and 20% 
O2. 
2.3. Signaling molecules screening from RNA sequencing 
I reasoned that at a certain point of trophoblast lineage commitment, a stage that 
precedes syncytiotrophoblast formation, cell surface receptors that may mediate fate 
decisions in the trophoblast lineage would be expressed. The identification of such 
receptors would provide insight into possible extracellular ligands that may influence 
trophoblast progenitor fate. It is such ligands that I aimed to identify so that I may 
implement these in my HCS. To identify such receptors I mined mRNA-seq data of 
hESCs differentiated for eight days with the SB differentiation protocol directed 
towards the trophoblast lineage. This data was previously generated by graduate 
student   in   Dr.   Robson’s   laboratory   (Herath,   2011).   A   list   of   various   signaling  
molecule receptors was obtained. The completed potential receptors list was consisted 
of ten signaling molecules receptors with their each corresponding ligand. The 
selection was carried out based on gene Reads Per Kilobase per Million mapped reads 
(RPKM) value with ≥2.5 cut-off points and gene expression fold change with ≥2.0 
cut-off points. Among total shortlisted genes, the genes correspond to signaling 
molecule receptors then chosen by aligning with list of human receptors in National 
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Center for Biotechnology Information (NCBI) using integrated Panther protein 
database. The top list of up-regulated signaling molecule receptors were chosen based 
on the selection criteria as described previously. The receptor list was then finalized 
and  each  receptor’s  ligand  was  chosen  by  further literature studies. 
2.4. Human embryonic stem cells-derived trophoblast differentiation towards 
invasive syncytiotrophoblast 
Further differentiation was carried out following the initial SB differentiation. After 
the hESC culture was differentiated with SB treatment towards trophoblast lineage for 
three days, the SB treatment removed and the culture was further treated with the 
respective ligands of interest (Table 2.1) to observe their effects on cell morphology. 
The culture media used was adapted and modified from Baczyk, et al. (2009), 
specifically   this   contains   Dulbecco’s  Modified   Eagle   Media:Nutrient Mixture F/12 
Media (DMEM-F/12 1:1; GIBCO, Life Technologies) supplemented with Insulin-
Transferin-Selenium (ITS)-X supplement (GIBCO, Life Technologies), 1 mM of L-
Glutamine (GIBCO, Life Technologies), and 100X of penicillin-streptomycin 
(GIBCO, Life Technologies). The differentiation basal media were mixed properly 
and filter-sterilized. The culture media then mixed with selected signaling molecules 
for various further differentiation platforms. The list of signaling molecules were 
Chemokine (C-C motif) Ligand 21 (CCL21; Life Technologies), Brain-Derived 
Neurotrophic Factor (BDNF; Life Technologies), Retinoic Acid (RA; Sigma-
Aldrich®), Colony Stimulating Factor-3 (G-CSF/CSF-3; Life Technologies), 
Keratinocyte Growth Factor or Fibroblast Growth Factor-7 (KGF/FGF7; Life 
Technologies), Hepatocyte Growth Factor (HGF; R&D Systems), Epidermal Growth 
factor (EGF; Life Technologies, Folic Acid (FA; Sigma-Aldrich®), 15-deoxy-Δ12,14-
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prostaglandin J2 (PGJ2; Sigma Aldrich®), Granulocyte Macrophage-Colony 
Stimulating Factor (GM-CSF; Life Technologies), and Brain Morphogenic Protein-4 
(BMP4; R&D Systems). 
2.4.1. High content screening (HCS) 
The Morphology Explorer BioApplication software from Cellomics® High Content 
Screening platform (Thermo Scientific) was used to analyze the cells morphology 
features. The 96 wells cell culture plate was coated accordingly by dispensing 50uL 
diluted   Matrigel™   (BD   Bioscience)   and   was   incubated   at   37oC for one hour to 
polymerize. The hESC culture that already reached 80% confluence was sub-cultured 
onto Matrigel-coated 96 wells culture plate. The hESC culture then was differentiated 
towards trophoblast lineage according to the standard protocol as described before. 
Each of the well of the culture plate contained 100uL of cells suspension. On the 
following day, the culture was washed with DMEM-F/12 1:1 and SB differentiation 
media were added and replaced daily. After three days of SB treatment, the hESC-
differentiated trophoblast culture was ready to be further differentiated.  
The culture media was aspirated out and the culture washed one time with DMEM-
F/12 1:1. There were eleven signaling molecules to be added into the differentiation 
basal media. The differentiation basal media containing each signaling molecule was 
prepared in advance. The culture treated with each and every signaling molecule with 
various concentrations following arrangement of treatment as described in Figure 2.1. 
The culture media was changed daily for three days with each 24 hours time point 
experiment. The screenings were carried out in two independent experiments and 
were statistically analyzed using two-tail student t-test method.
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Figure 2.1. The 96 wells culture plate arrangement of various signaling molecules treatment for HCS platform. 
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At the end of each experiment, the cultures were fixed with 2X Prefer non-formalin 
Fixative (Anatech Ltd) by adding 100uL of fixative solution into each well without 
aspirating out the culture media. The culture was fixed at room temperature for 15 
minutes and  followed  by  three  times  washing  with  1X  Dulbecco’s  Phosphate  Saline  
Buffer (DPBS; GIBCO, Life Technologies). The cells membrane permeabilization 
was done by adding 0.3% Triton X-100 (Molecular Grade, Promega) in DPBS and 
incubation at room temperature for 15 minutes. The culture then was washed three 
times with DPBS and incubate with 1ug/ml of HCS CellMask™-Red Stain 
(Molecular Probes®, Life Technologies) in DPBS at room temperature for 30 minutes 
to stain the whole cells. For cells nuclei, the staining was done using 2.5 ug/ml 
HOECHST – Trihydrochloride, Trihydrate (Molecular Probes®, Life Technologies) in 
DPBS and was incubated at room temperature for 12 minutes. Finally, the stained 
culture was washed one time with DPBS and was submerged in DPBS until the 
visualization and analysis by HCS system.  
During visualization by HCS platform, the stained culture plate was loaded into the 
Cellomics®ArrayScan® VTI Reader (Thermo Scientific) and the scanning protocol 
were set to Morphology Explorer BioApplication with 10 fields were captured for 
each well. The scanning followed the HCS recommended standard visualization 
protocol generated by the company (Cellomics®, Thermo Scientific). The ArrayScan® 
VTI Reader generated two types of results. First, the qualitative results in forms of 
image of each captured field and was given in .TIFF image format. Second, the 
quantitative results were generated from the automated measurements of several 
selected morphology parameters (Table 2.2) based on the optimized threshold values.
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Table 2.1. Morphology features selected for measurement in HCS Cellomics®ArrayScan® VTI Reader. 
 
Morphology Features Definition 
Valid Cell Count  Number of valid cell identified in the well 
Cell Area  Cell area for all cells selected for analysis in the well 
Cell Length  Length of cell aligned bounding box for all cells selected for analysis in the well 
Cell Width  Width of cell aligned bounding box for all cells selected for analysis in the well 
Nucleus Count  Number of valid nucleus identified within cell for all cells selected for analysis in the well  
Nucleus Cell Area Differences Difference of nucleus area compared to cell area 
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2.4.2. Fusion rate quantification using immunofluorescence confocal microscopy 
The fusion rate quantification was done to validate the HCS result. The quantification 
protocol was referred from Chang, et al. (2008) and was consisted of two main steps. 
First, the immunofluorescence staining was done using membrane stain and was 
counter-stained with nuclei stain following the standard immunostaining protocol. For 
staining, the culture media was aspirated out and the cells were washed twice with 
DPBS. Next, the culture was fixed with ice-cold 4% paraformaldehyde (PFA) and 
was incubated at room temperature for 30 minutes. The culture then was washed with 
DPBS before permeabilization with 0.3% of Triton X-100 in DPBS at room 
temperature for 5 minutes. To prevent any unspecific binding, the culture were 
blocked  with  mixed  “Blocking  Solution”  of 0.5% of Bovine Serum Albumin (BSA; 
PAA Laboratories) and 5% standard Fetal Bovine Serum (GIBCO, Life 
Technologies) in DPBS, at room temperature for 30 minutes. The culture was 
incubated with primary antibody for cell membrane staining, which was 5 ug/ml of 
anti E-Cadherin (HECD-1; ab-1416, Abcam®), at 4oC for overnight. On the following 
day, the culture was washed three times with DPBS to get rid the remaining primary 
antibody and probed with 1:1000 dilution of secondary antibody AlexaFluor® 488-
conjugated IgG (Molecular Probes®, Life Technologies) for one hour at room 
temperature in the dark condition. The culture was washed three times with each time 
for 5 minutes prior to staining with nuclei stain,   which   was   4’,6-diaminido-2-
phenylindole, dihydrochloride (DAPI; Molecular Probes®, Life Technologies) at 
room temperature for 12 minutes. Lastly, the culture was washed once with DPBS 
and sealed with mounting media (FluorSave™; Calbiochem®, MERCK Millipore) for 
long-term storage in 4oC. 
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The confocal microscopy was used for better and detailed culture visualization. The 
stained culture plates were visualized using Inverted Zeiss LSM 510 Meta Confocal 
Microscope (Carl Zeiss) with 20X objective lens magnification. There were three 
wells as representative of technical replicates for each treatment and five fields 
(images) were taken from each well for fusion quantification. All the images were 
processed and quantified using FIJI (ImageJ, National Institute of Health). The Fusion 
Rate was measured from each image by counting number of nuclei that was belonged 
to one cell compartment and was divided by total number of nuclei counted in the 
image. The fusion rate was presented in percentage format (Figure 2.2). The fusion 
measurements were done in three independent experiments and statistically analyzed 
using two-tail student t-test method. 
Figure 2.2. The calculation formula to quantify the percentage of the 
fusion rate. 
   
 
2.4.3 Validation of invasive syncytiotrophoblast markers using immunofluores-
cences microscopy 
Immunofluorescence staining was carried out for validation of various cellular 
markers of invasive syncytiotrophoblast. First, the H1 culture was differentiated to 
trophoblast lineage by SB treatment for three days. The culture was further treated 
several shortlisted signaling molecules for subsequent three days. At the end of the 
treatment, the culture media was aspirated out and the culture was washed twice with 
DPBS for 5 minutes and was fixed with 4% of PFA for 30 minutes at room 
temperature. After fixation, the culture was permeabilized with 0.3% of Triton X-100 
Fusion Rate (%) = Number(s) of nuclei in fused region       x      100% 
Total number(s) of nuclei 
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in DPBS for 5 minutes at room temperature to facilitate an intracellular staining. In 
order  to  prevent  unspecific  antibody  binding,  the  culture  was  blocked  with  “Blocking  
Solution”   for  30  minutes  at   room   temperature.  The  culture  was   then   incubated  with  
one or combination of primary antibody at 4oC for overnight (Table 2.2). On the 
following day, the culture was washed three times with DPBS to get rid the remaining 
primary antibody and stained with secondary antibody AlexaFluor®-conjugated IgG 
(Molecular Probes®, Life Technologies) against specific species used in primary 
antibody for one hour at room temperature in dark condition. The culture was washed 
two times with each time for 5 minutes and stained with AlexaFluor® 488 Phalloidin 
dye for F-Actin labeling for 20 minutes at room temperature and protected from light. 
The culture then was washed three times with each time for 5 minutes and incubated 
with nuclei stain, which was DAPI at room temperature for 12 minutes. Lastly, the 
culture was washed once with DPBS and sealed with mounting media (FluorSave™; 
Calbiochem®, MERCK Millipore) for long-term storage in 4oC. 
The fixed fluorescence microscope (Zeiss Cells Observer Z.1; Carl Zeiss) was used to 
visualize the fluorescence staining. The immunofluorescence staining pictures were 












Specificity Species Conc. 
Catalog 
Number Company 
E-Cadherin Extracellular domain 
Mouse 
Monoclonal 1:200 ab1416 Abcam 
GCM-1 Transcription factor 
Mouse 
Monoclonal 1:50 ab88748 Abcam 
Syncytin 1 Surface origin Rabbit Polyclonal 1:100 sc-50369 
Santa 
Cruz 
Cytokeratin 7 Cytoskeleton Mouse Monoclonal 1:200 M7018 Dako 
hCG beta Hormon Mouse Monoclonal 1:50 ab763 Abcam 
MMP-14 AA160-173 Rabbit Polyclonal 1:100 ab3644 Abcam 
MMP-14 Catalytic domain 
Mouse 
Monoclonal 1:100 ab78738 Abcam 
Furin Full length Rabbit Polyclonal 1:100 ab3467 Abcam 
EGFR Extracellular domain 
Mouse 
Monoclonal 1:100 ab30 Abcam 
Integrin beta Full length Mouse Monoclonal 1:100 ab30394 Abcam 
 
2.4.4 Validation of invasive syncytiotrophoblast marker using western blot 
Western blot detection was carried out for validation of cellular marker of invasive 
syncytiotrophoblast, which was matrixmetalloproteinase-14 (MMP-14/ MT1-MMP). 
First, the H1 culture was differentiated to trophoblast lineage by SB treatment for 
three days. The culture was further treated several shortlisted signaling molecules for 
subsequent three days. Afterwards, the cells were scraped and were spin down at 
850rpm for 3 minutes to collect the pellet. The pellet was then lysed with RIPA buffer 
(Sigma Aldrich®) supplemented with proteinase inhibitor (PI; Sigma Aldrich®) for 
two hours at 4oC. In order to collect the supernatant, the lysate were spin down a
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12000rpm for 20 minutes at 4oC. The protein supernatant were measured by Bradford 
Protein Quantification Assay and kept at -80oC for long-term storage. 
For western blot detection, 40ug of protein supernatant were mixed with sample 
buffer added with denaturing agent and incubate at 95oC for 5 minutes to denature the 
protein. Afterwards, the proteins were loaded into the wells of 12% acrylamide gel 
(Bio-Rad Laboratories, Inc) and Precision Plus Protein™ Kaleidoscope™   standard  
(Bio-Rad Laboratories, Inc) was used as a molecular weight standard. The gel was run 
at 100V for 1.5 hours. After running, the proteins were transferred onto a PVDF 
membrane using electroblotting method at 200 mA for 45 minutes. The PVDF 
membrane then blocked with 5% milk in PBST (0.1% of Tween in PBS) for one hour. 
The membrane was incubated with primary rabbit antibody against MMP-14 
(Abcam®) at 4oC for overnight. Before secondary antibody incubation, the membrane 
was washed three times (each 15 minutes) with PBST and incubated with HRP-
conjugated donkey secondary antibody against rabbit IgG (Santa Cruz Biotechnology, 
Inc.) for 1 hour at room temperature with shaking. The membrane then was exposed 
to Amersham ECL™ Plus Western Blotting substrate (Pierce; GE Healthcare UK 
Limited) and wrapped in the saran plastic and placed in the western blot cassette. 
Finally, a film was exposed to the membrane and developed in the dark room using 
standard film developing protocol. 
2.4.5 Detection of Human Chorionic-Gonadotrophin (hCG) Production 
One of the syncytiotrophoblast characteristics is the production of human Chorionic 
Gonadotrophin (hCG) hormone. Thus, detection of hCG production in the treated 
culture was performed in order to further validate the formation of 
syncytiotrophoblast. First of all, H1 culture was differentiated towards trophoblast 
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lineage using SB treatment for three days. The H1-differentiated trophoblast then 
treated with selected combination of signaling molecules for subsequent three days. 
To check the hCG production from the culture, culture media from each time point, 
which was 24 hours, 48 hours, and 72 hours, were collected for measurement. The 
culture media then was spun down at 1500rpm for 3 minutes to get rid of any cell 
debris or dead cells. The culture media is aliquoted into 1 mL eppendorf tube and 
stored in the -20oC for future measurement. The culture media samples were then sent 
out to Department of Laboratory Medicine, National University Hospital for hCG 
measurement. The experiments were done in three independent biological replicates.  
The gene expression study of known trophoblast markers using Real-Time PCR 
technique was performed. After H1 culture being differentiated towards trophoblast 
lineage with SB treatment and further differentiated using selected signaling 
molecules, the cells then were harvested and lysed following the RNA isolation 
standard protocol. First, the culture was washed with PBS for two times to completely 
remove the remaining growth media. The ice-cold TRIZOL® RNA Isolation (Life 
Technologies) reagent was used to lyse the cells by dispensing 1 ml of TRIZOL into 
one well of six wells plate. The cells were re-suspended to facilitate the lysing and 
dispensed into a 1.5 ml eppendorf tube. 200 ul chloroform was added per 1 ml 
TRIZOL to denature the proteins and separate them into organic phase or interphase 
from RNA that remains in aqueous phase. The cells lysate were spun down at 12000 
rpm for 15 minutes at 4oC to create different interphases that enable the clean RNA 
extraction. After collecting the RNA in the aqueous phase by avoiding the other 
phases, the RNA then was precipitated by adding 500 ul Isopropanol (per 1 ml 
TRIZOL). The RNA was incubated for 10 minutes at room temperature and 
centrifuged down at 12000 rpm for 10 minutes at 4oC to pellet down the RNA. After 
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centrifugation, the RNA pellet becomes visible and the isopropanol were carefully 
decanted out. The RNA pellet was washed with ice-cold 70% Ethanol (EtOH) by 
vortexing and was spun down at 10000 rpm for 5 minutes at 4oC. The ethanol was 
carefully and completely removed after centrifugation leaving the RNA pellet at the 
bottom of the eppendorf tube. The next step was to further clean the RNA by 
processing through the RNA purification column following the standard protocol by 
RNeasy® Mini Kit (QIAGEN). The RNA quantity was measured using NanoDrop 
ND-1000 (ThermoFisher Scientific). The RNA was then stored in the -80oC for long-
term usage. 
For the reverse transcription Polymerase Chain Reaction (PCR) process, High 
Capacity cDNA Reverse Transcription Kit from Applied Biosystem (Life 
Technologies) was used. Approximately 1 ug of RNA were used as a starting amount 
for every sample by diluting with RNase-free water (QIAGEN). By depending on the 
number of sample, a master mix containing all reagents from the PCR kit (Table 2.4-
a) was prepared. Afterwards, the master mix and the diluted RNA sample (1ug) were 
dispensed and mixed together in the PCR tube. The thermal cycler (PCR) machine 
then was set up to the standard condition for reverse transcription PCR (Table 2.4-b). 
After cDNA synthesis, samples preparation for Real-Time PCR (RT-PCR) were done 
by diluting total volume of 20 ul cDNA product with ratio of 1:10 with RNase-free 
water. The TaqMan® Assay was used in the RT-PCR. In the TaqMan Gene 
Expression protocol, 5 ul of 2x TaqMan Universal PCR Master Mix (Applied 
Biosystem; Life Technologies) were mixed with 0.5ul of TaqMan assay probe (Table 










Table 2.3 Reverse transcriptions PCR master mix composition (a) and 














Table 2.4 List of TaqMan Assay probes that were used in the RT-PCR.
Reagent Volume of total 20ul/ reaction (ul) 
10x RT Buffer 2 
25x dNTPs mix (100mM) 0.8 
10x Random Primers 2 
Multiscribe™ reverse 
transcriptase 1 
1ug RNA sample X 
RNase-free water X – top up to 20ul 
Temperature (oC) Time (minutes) 
37 120 
85 5 
GCM1 PGF CDX2 
SYNCYTIN 2 TFAP2A NANOG 
CGA GATA3 SOX2 







CHAPTER 3: RESULT I 
Signaling Molecules 




3.1. High Content Screening (HCS) background 
With advances in scientific technology over two decades, researchers manage to 
deeply explore and answer various extraordinary biological questions. Developments 
in molecular biology, such as microarray and DNA/RNA sequencing technologies 
have provided countless new molecular information and insight, such as Human 
Genome Project, to be further explored. These molecular technology developments 
also create and enable investigation into new levels of biological processes, such as 
transcriptomics, proteomics, and metabolomics. However, the works to connect the 
huge amount of genetic information with cellular phenotypes or behaviors have 
generated limitations and challenges in addressing cellular complexity. Advances in 
fluorescence microscopy have become one of the powerful tools to explore the spatio-
temporal events in systems biology by providing wide spectrum range of fluorophores, 
which also provides remarkable understanding into complex cellular events. Despite 
the capability of the fluorescence microscopy, the laborious and time-consuming 
platforms is mostly incompatible with the high-throughput purposes (Abraham et al., 
2004). In order to solve the limitation of small-scale fluorescence microscopy, the 
system that implements automated fluorescence microscopy and advanced imaging 
processing tools to generate quantitative cellular imaging data and provide detailed 
knowledge of certain components or molecules towards cellular responses, were 
created.  
High Content Screening (HCS) is an advanced high-throughput platform to facilitate 
the understanding of cell biology in response to a particular treatment regime by 
quantitatively imaging cellular processes such as cell morphology, intracellular 
trafficking, cytotoxicity, apoptosis, cell signaling, and protein localization (Bitler et 
al., 2013; Giuliano et al.; Yan et al., 2013). HCS is specifically defined as the 
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automation of high-content based cellular biology involving arrayed cells. Essential 
considerations in a successful HCS experiment are experimental design, sample 
preparation, image acquisition, archiving, processing, and analysis, and ensuring the 
capture of detailed and robust cellular knowledge (Figure 3.1). The capability of the 
system to define various spatial and temporal processes reflecting the structural and 
functional integrity of each individual cell within the array of cells is the main 









Figure 3.1. The High Content Screening (HCS) experimental pipeline 
from addressing biological question to generate cellular knowledge 
(Abraham et al., 2004). 
HCS provides various integrated tools that have been developed by Cellomics, Inc. 
(www.cellomics.com) and widely used to investigate broad cellular activities. 
Cellular features of interest are marked by fluorescence that can be captured by the 
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imaging system. This fluorescence marking can be achieved by the use fluorescently 
labeled antibodies, genetically encoded fluorescent protein (e.g. EGFP fused to 
protein of interest), organic dyes, or quantum dots (QDs). This is then combined with 
image capture and the analysis of multiple parameters, thus allowing HCS the ability 
to screen many candidate compound(s) for their affects not only on levels of protein 
expression but also alterations in sub-cellular localization of proteins and/ or cellular 
components (Zanella et al., 2010). Thus, many subtle differences in cell phenotype 
and/or fluorescence protein expression can be observed in a HCS time-course 
experiment. For instance, an analysis of mitotic delays and its corresponding 
phenotype during cells division (Neumann et al., 2010);(Harder et al., 2009). Besides 
a time-point or kinetic experiments, the HCS system also can be utilized to investigate 
the biological consequences of small molecules on cells by using an end-point assay 
to measure phenotypic change based on cellular structure or morphology using fixed 
cells and measureable by an image-based assay. Examples of this are tracking cellular 
differentiation from stem or progenitor cells by measuring cytoskeletal rearrangement 
or changes in cell shape (Treiser et al., 2010);(Mioulane et al., 2012);(Low et al., 
2010) or measuring specific sub-cellular structure formation such as invadopodia 
(Quintavalle et al., 2011), perinucleolar compartments (PNC) in metastatic cancer 
(Norton et al., 2009), or neurite outgrowth (Laketa et al., 2007), and myoblast 
formation (Krueger and Hoffmann, 2010). 
The ability of HCS systems to measure in high-content and multiple parameters 
simultaneously makes this a promising tool in stem cell biology (Barbaric et al., 2010). 
For example, HCS was used to screen approximately 3500 compounds on hESC cells 
and identified several molecules of interest that have similar phenotypic outcome as 
those of retinoic acid treatment (Jee et al., 2012). Another successful HCS aimed at 
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identifying molecules directing hESC to Pdx1-positive pancreatic progenitor cells 
identified a single small molecule that increased the percentage Pdx1-expressing cells 
(Chen et al., 2009). Such success in applying HCS to pluripotent stem cell 
differentiation attracted me to applying this system in my thesis.  
As this was the first morphology-based screen of hESC differentiation towards 
trophoblast lineage, there were multiple factors that needed to be optimized. In the 
following sections I describe the optimizations of the cell culture conditions and 
growth media, before describing the HCS system parameter adjustment, the selection 
of the growth factors and cytokines to be used in the screen, and finally the HCS 
analysis itself. 
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  Figure 3.2. The experimental outline in hESC differentiation for further trophoblast sub-types derivation.  
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3.2. Cell culture optimization 
Each individual cell type has its own optimal growth conditions so first I sought to 
optimize these in the context of the 96-well HCS system. The multiple parameters to 
test in developing the baseline growth conditions are: type of extracellular matrix 
coating of wells, density of cells to seed, timing of cell passaging, and point of 
differentiation along the trophoblast lineage prior to screening. 
The experiment was started with H1 hESC line that was grown on Matrigel-coated 
plate until 80% confluency. The undifferentiated or pluripotent H1 hES cell line was 
derived from human blastocyst and has normal XY karyotype (Thomson, et al., 1998). 
This hES cell line is one of the two NIH-approved embryonic stem cell lines, which is 
also  considered  as  a  “gold  standard”  for  human  embryonic  stem  cells  study  and  one  of  
the most extensively studied and characterized (Schuldt et al., 2013; Scott et al., 2009). 
The morphology of H1 hES cell line that was already reported has very compact 
colonies with distinct borders, which composed by small round cells, each with large 
nuclei and notable nucleoli, similar as shown in Figure 3.3 (a). The extracellular 
matrix coating is an essential factor in ensuring healthy growth of H1 cells on feeder-
free system. Numerous reports have been published to establish and optimize a proper 
choice of basement membrane components for H1 cell culture, for example 
fibronectin (Tsutsui et al., 2011), laminin (Li et al., 2005), and type-1 collagen (Furue 
et al., 2008). Another type of extracellular matrix that has been widely used in H1 
culture is Matrigel, which is a combination of various basement membrane 
components, mostly laminin, collagen IV, and heparan sulfate proteoglycan (Bissell et 
al., 1987; Kleinman et al., 1982). As reported by Xu, et. al. (2001), four hES cell lines, 
including H1, were successfully maintained on matrigel for the longest culture time. 
Moreover, the H1 long-term culture on matrigel also retained the pluripotent 
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morphology and karyotype, and also expressed pluripotent markers, such as SSEA-4, 
OCT-4, Tra 1-81, and hTERT. In this project, all of the H1 cultures were properly 
maintained on matrigel.  
 




Figure 3.3. The morphology of H1 pluripotent stem cells (a) and H1-
differentiated trophoblast population (b). The H1 feeder-free culture was 
on Day 3 growth and the H1-differentiated trophoblast culture was on 
Day 3 of SB treatment. All of the pictures were taken using inverted light 
microscope with total magnification of 50X. 
Upon reaching 80% confluency, ESCs were subcultured onto matrigel-coated plates 
for initial differentiation towards trophoblast lineage. The established protocol in Dr. 
Robson’s  lab  uses the combination of FGF-signaling inhibitor, SU5402 and BMP4 or 
SB differentiation (Figure 3.2(2)). The morphology differences can be observed in 
the H1 differentiation towards trophoblast lineage. The hES-differentiated trophoblast, 
as reported by Xu, et. al. (2002), underwent morphology transformation into more 
flattened and enlarged cells with epithelial-like features and sparser colony density. 
The similar morphology features were also observed in H1-differentiated trophoblast 
by SB treatment (Figure 3.3 (b)). The time-length of SB differentiation was included 
as necessary to be optimized (Figure 3.2(3)). According to the hES cells 
differentiation protocol that is available and already optimized in our lab, hES cells 
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are committed to trophoblast lineage upon 48 hours of differentiation, which means 
the withdrawal of SB factors after the commitment time point will not reverse the 
cells back to pluripotent stage. In the SB differentiation experiment, two time points, 
72 hours and 96 hours, were compared for optimization. As showed in the Figure 3.4, 
the differentiation of H1 towards trophoblast lineage was yet observed within 24 
hours of SB treatment (Figure (a)), which the differentiation started at the periphery 
(Figure (b)) and moved towards the center of the colony (Figure (c)-(d)). Since the 
H1-trophoblast differentiation was not uniform, the differentiation should be 
completed towards the center of the colony and to ensure no remaining pluripotent 
cells prior to further differentiation. To confirm the differentiation works towards 
trophoblast lineage, molecular expression using real-time PCR was done for various 
trophoblast and pluripotency markers. As shown in the graph of gene expression 
results (Figure 3.3 (e)), upon 72 hours of SB treatment, there were significant up-
regulation of trophoblast markers up to around 1000 folds, such as GATA3, TFAP2A, 
and HAND1, while there were down regulation of various pluripotency markers, such 
as OCT4, NANOG, and SOX2. Thus, based on the morphological and molecular 
expression validation, the most efficient length of SB differentiation was 72 hours, 
when the duration already passed the commitment time-point and overall culture 
already differentiated completely, while it was also the earliest time-point to possibly 
capture early sub-population of trophoblast lineage.   
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Figure 3.4. The morphology of H1-differentiated trophoblast by SB 
treatment for 4 days. The H1-differentiated trophoblast culture 
morphological progression upon 24 hours (a), 48 hours (b), 72 hours (c), 
96 hours (d) of SB treatment. The differentiation was then validated by 















Pluripotency and Trophoblast Markers 
Gene Expression of Trophoblast Day 3 
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To validate the robustness of the differentiation protocol, several types of basal media 
for SB differentiation were tried. First, the 20 uM of SU5402 and 100 ng/ml of BMP4 
were mixed into hES basal media, as described in the established SB differentiation 
protocol. Second, the same concentration of SU5402 and BMP4 were combined into 
the mTeSR media or commercialized growth media for hES cells (SB-mTeSR). In 
terms of morphological features, the H1 culture that was differentiated with SB-
mTeSR exhibited similar morphology as compared to the H1 culture that was treated 
with standard SB differentiation protocol (Figure 3.5). However, it took a longer time 
for the differentiation process to reach towards the center of the colony, which was 
more than 96 hours in the culture treated with SB-mTeSR. While, in the culture that 
was differentiated using standard SB protocol, it took only 72 hours to complete the 
differentiation. This result was expected and possibly caused by the contrary effect of 
various factors exist in mTeSR media, such as bFGF and TGF-β, that support the 
pluripotency and self-renewal of the hES cells, thus slower the differentiation process. 
Furthermore, based on the molecular expression data of H1-differentiated trophoblast 
from SB-mTeSR treatment for various trophoblast markers and pluripotent markers 
by real-time PCR analysis, there were still significant up-regulations of various 
trophoblast markers and down regulations of several pluripotency markers (Figure 
3.5 (c)), even though the culture differentiation needed around 4 days to reach similar 
fold change value in the molecular expression as compared to standard SB 
differentiation protocol. In summary, the SB standard differentiation protocol was 
proven to be robust to support the H1 differentiation towards trophoblast lineage, 
even at the presence of various factors that support the characteristics of pluripotent 
stem cells (Figure 3.2(4)).  
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Figure 3.5. The morphology comparison of H1-differentiated trophoblast 
using SB-mTeSR (a) and SB standard differentiation protocol (b). Both 
of the cultures were maintained at the same period of growth, which is 
four days. At the end of differentiation, the SB-mTeSR culture was 
harvested and real-time PCR analysis was performed to investigate the 



















Pluripotency and Trophoblast Markers 
Gene Expression of Trophoblast Day 4th 
(SB-mTeSR) 
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Before processing to subsequent signaling molecule-based differentiation to 
investigate various trophoblast lineage subtypes, some optimization regarding culture 
growth conditions and cell seeding numbers were performed for HCS system (Figure 
3.2(6)). Since the H1 proper growth requires the support of extracellular matrices, the 
matrigel was used to coat the 96 wells plate. Two different conditions of sub-cultures 
were tested. First, the H1-differentiated trophoblast culture that was already treated 
with SB media for three days was dissociated into a single cell and the cells were 
counted then plated in several seeding numbers. Because human pluripotent stem 
cells are very sensitive in terms of cell-cell contact, which it prefers and survive better 
in colony form, the ROCK inhibitor (Y-27632; Merck, Calbiochem) was added into 
the seeding media with 20 uM final concentration. ROCK inhibitor is a small 
molecule that has a role in supporting the cells survival by inhibiting p160 Rho-
associated coiled kinase (p160ROCK), which is one of the apoptotic cascade 
components (Narumiya et al., 2000; Riento and Ridley, 2003). ROCK inhibitor has 
been commonly used to improve the survival of dissociated hPS cells, which can be 
caused by sub-culturing (Watanabe et al., 2007). Figure 3.6 shows the H1-
differentiated trophoblast, which was seeded with ROCK inhibitor added into the 
culture media, managed to survive 24 hours prior to sub-culture. As comparison, the 
H1-differentiated trophoblast that was not supplemented with ROCK inhibitor during 
first 24 hours after seeding showed significant cells death, which was indicated by 
floating cells. The ROCK inhibitor treatment was limited to not more than 24 hours 
incubation to prevent any non-specific effect on culture. To determine the proper H1-
differentiated trophoblast cells density for HCS system and by utilizing ROCK 
inhibitor treatment prior to subculture, three different seeding numbers were tried, 
which were 3000 cells/ well, 5000 cells/ well, and 8000 cells/ well.  
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Figure 3.6. The comparison of H1-differentiated trophoblast cells upon 
sub-culture, ROCK inhibitor incubation prior to sub-culture (a) and 
without ROCK inhibitor incubation (b). Both of the cultures were 
dissociated with 0.05% Trypsin at the end of the 3rd day of SB 
differentiation and seeded onto matrigel-coated culture microplate. 
As seen on Figure 3.7, the culture that had 3000 cells/ well as seeding density showed 
a very sparse condition as compared to others, while the culture that contains 8000 
cells/ well at the time of seeding, showed a too dense population and almost covering 
entire growth surface. Based on the comparison between seeding numbers, the culture 
that has 5000 cells/ well seeding density exhibited the most proper growth and 
differentiation. When the seeding density was too low, the cells did not survive at the 
end of treatment. This might be due to the effect of certain signaling molecule that 
supports the cells to undergo terminal differentiation and detach from the surface, 
while the low number of cells are not adequate to replace the dead cells. On the other 
hands, when the cells were seeded in a high density or crowded, the differentiation 
was not efficient as compared to optimum cells density. Burres & Cass (1986) 
investigated the effect of cells density towards syncytiotrophoblast markers 
expression in BeWo choriocarcinoma cell line, which the expression were reduced in 
crowded culture. 
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Figure 3.7. The comparison of different seeding number of H1-
differentiated trophoblast cells 24 hours upon sub-culture; 3000 cells/ 
well (a), 5000 cells/ well (b), and 8000 cells/ well (c). All of the cultures 
were dissociated with 0.05% Trypsin at the end of the 3rd day of SB 
differentiation, incubated with 20uM of ROCK inhibitor and seeded onto 
matrigel-coated culture microplate. 
 
The second set experiment for HCS culture optimization was to avoid subculture 
between SB differentiation and subsequent signaling molecule differentiation. The H1 
cells were subcultured using standard protocol into matrigel-coated 96 wells plate and 
were differentiated using SB towards trophoblast lineage for three days. Subsequently, 
upon withdrawal of SB treatment, the H1-differentiated trophoblast cells were treated 
with various signaling molecules for further differentiation. In terms of seeding 
number, the subculture ratio was similar or comparable to 5000 cells/ well, which was 
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1:96 (1 well of 6 wells plate to whole 96 wells plate). Also, this method eliminated 
the need to use ROCK inhibitor treatment prior and after subculture. By referring to 
several publications, ROCK inhibitor has some involvement in cells differentiation, 
including trophoblast differentiation. For example, ROCK inhibitor is known to 
regulate renewal and density-dependent neural differentiation in mouse embryonic 
stem cell (Chang et al., 2010). Fafet, et al. (2008) reported the involvement of ROCK 
inhibitor as a regulator in extravillous cytotrophoblastic cells (EVCTs) invasion and 
migration in placental-endometrial co-culture system. Moreover, Sivasubramaiyan, et 
al. (2009) described the involvement of ROCK inhibitor in blastocyst-like embryoid 
bodies differentiation towards trophoblast lineage. Based on those previous reports, 
ROCK inhibitor has a possibility of affecting the culture differentiation, which is not 
the purpose of this differentiation experiment. 
3.3. Growth media optimization 
Besides culture optimization, the other important factor was growth media 
optimization for signaling molecules treatment (Figure 3.2(6)). Next step in HCS 
optimization was to decide the appropriate basal media for further differentiation. 
There has been various type of basal media for trophoblast differentiation available. 
The usage of the basal media is depended on several criteria, such as types of cell, 
source of samples, growth period, and composition. Based on extensive literature 
studies, several potential basal medias were chosen (Table 3.1). Most of the basal 
medias were used to temporarily maintain cytotrophoblast cells that were isolated 
from late first trimester of pregnancy. According to the purpose of this study, which is 
the investigation of various signaling molecules that affect trophoblast differentiation, 
basal media with minimum or no addition of signaling molecules, such as cytokine or 
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growth factor was chosen. From the selection, several basal medias supplemented 
with signaling molecules, such as EGF (James et al., 2005; Li and Zhuang, 1997), 
FGF4, heparin (Harun et al., 2006), and Nutridoma (Zhou et al., 2002), which will 
affect the differentiation. Therefore, two basal medias that do not contain any 
signaling molecules were used as a comparison. The cells number comparison 
between cultures that was grown with basal media from Petroff, et al. (2006) and 
Baczyk, et al. (2009) showed there was a significant cell number difference. As 
shown on Figure 3.8, the culture that was grown using basal media from Baczyk, et 
al. (2009) for 72 hours of growth, has a higher number of cells as compared to serum-






Figure 3.8. The comparison of cells quantity between cultures that were 













Valid Cell Count - 72 hours culture 
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Table 3.1. Selection of various basal medias for signaling molecules trophoblast differentiation in HCS system. 
Media 
No. Cell Type Source Composition 
Length of 
Maintenance Reference 
1. H7 & H14 hESC 
RPMI-1640, 20% FBS, 1mM sodium 
pyruvate, 100uM β-mercaptoethanol, 
2mM L-glutamine, FGF4, Heparin 





DMEM F/12 (1:1), 10ng/ml EGF, 10ug/ml 
insulin, 0.1% BSA, 2mM L-glutamine, 
1.75mM Hepes 
2 days (Li, et al., 1997) 




DMEM F/12 (1:1), 10% FBS, 5ng/ml 
EGF, 5ug/ml insulin, 10ug/ml transferrin, 
20nM sodium selenite, 400U/L HCG 
4 days (James, et al., 2005) 
4. Villous cytotrophoblast 
1st – 2nd 
trimester 
placenta 
Serum-free DMEM-High Glucose, 2% 
Nutridoma 2 days 
(Zhou, et al., 
2002) 
5. Cytotrophoblast Term placenta IMDM, 10% HI-FBS, 2mM L-glutamine 3 days 
(Petroff, et al., 
2006) 




DMEM F/12 (1:1), 2mM L-glutamine, 
5% ITS-X supplement 3 days (Baczyk, 2009) 
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Besides the main media component, another difference between both basal medias 
(Petroff, et al., 2006; Baczyk, et al., 2009) was the presence of serum. As described in 
Table 3.1, basal media from Petroff, et al. (2006) contains 10% of heat-inactivated 
Fetal Bovine Serum (FBS), while in the Baczyk, et al. (2009) the serum was replaced 
with Insulin Transferin Selenium (ITS) supplement. The ITS-supplement has a 
function as serum replacement by supporting the cell growth and substances uptake 
(Murakami et al., 1982). It contains Insulin that promotes glucose and amino acid 
uptake (Czech, 1977), also Transferin as iron carrier, which helps to reduce the effect 
of radical oxygen and peroxide (Furue et al., 2008; Murakami et al., 1982), and 
Selenium as antioxidant in the media (Klotz et al., 2003). Commonly, the unspecified 
components in the serum vary in terms of batch consistency and are possible to 
influence the culture differentiation. As reported by Chen, et al. (2011), the markers 
of syncytialization, such as Syncytin-1 expression and hCG production were 
increased in BeWo cell line by 8-br-cAMP induction with presence of serum in the 
media, such as FBS. Thus, factors that are contained in the serum affect the cells 
differentiation, including syncytialization process. In order to avoid any unspecified 
factors in the differentiation process, serum-free basal media from Baczyk, et al. 
(2009) were used as a basal media for downstream differentiation in HCS system.    
3.4. HCS software and measurement parameters optimization 
The advances of HCS have facilitated broad application in investigating various 
cellular processes, which are also come with the complexity of the system (Figure 
3.2(7)). The HCS utilizes fluorescence-based method, an advanced optical 
visualization system, and refined image analysis software. In this project, the HCS 
system was used to perform cytokines and/ or growth factors screening that affects the 
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morphology differentiation of H1-differentiated trophoblast towards various 
trophoblast subtypes. The Cellomics® Morphology Explorer software, as one of the 
integrated tools in BioApplication software, was used to analyze the morphological 
changes and provide the quantitative measurement, thus enables the screening of the 









Figure 3.9. The systematic outline of the process of defining cellular 
processes in HCS system. 
The Morphology Explorer has the capability to make morphological measurement in 
three-dimensional scales, from the morphology inside the cell (intra or sub-cellular 
morphology), the whole cell, and multi or inter-cellular morphology, for example 
colonies and multinucleated cells. Therefore, depending on the depth of measurement 
and the integration of all three-dimension information, the HCS manages to provide 
the whole morphology measurements by process described in Figure 3.9. The depth 
of certain morphology measurement can be performed with various available 
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fluorophores or different intensity of certain fluorophore by the Morphology Explorer 
software, which capable of identifying up to six different channels. Each of the 
channel is specified for certain target measurement, for example Channel 1 to 4 are 
intended for morphology targets, while Channel 5 and 6 are for target gating (Table 
3.2). 
Table 3.2. Various morphology features detection and measurement 
based on channel selection in HCS system. 











According to the purpose of this experiment to investigate the effect of various 
cytokines/ growth factors on the morphological changes of H1-differentiated 
trophoblast, channel one and channel two were used to identify and measure the 
changes, such as number of cells, cells area, number of nucleus and other morphology 
 86 
features (Table 3.2). Prior to analyze on HCS system, the cells were counter-stained 
with cytoplasm and nuclei dye, which enabled the detection by integrated 
fluorescence microscope. After being captured by the microscope, the software 
implemented the algorithm to perform intensity-based identification and further 
quantified the value for each morphology parameter. There are five types of algorithm 
in the morphology explorer to identify the cell, but only sub-set of them is available 
for each channel. Since in the experiment only two channels were used (Channel 1 
and Channel 2), there were only two types of algorithm can be used, which were 
“Isodata  Threshold”  and  “Fixed  Threshold”.  Channel 1 was used to label and identify 
whole   cell   and   described   as   “Object”,  while  Channel   2  was   used   to   identify   nuclei 
inside  each  cell  and  described  as  “Member”.  Based on the purpose of the experiment 
that started on the mixed population of trophoblast lineage and flexibility of the 
identification   protocol,   “Isodata Threshold”   protocol   was   chosen. This protocol 
allows adjustment of object or cell identification threshold (T) based on the average of 
the mean of the pixel intensities to the left of the threshold (mL) and the mean of the 
pixel intensities to the right of the threshold (mR) of the object with value between 1-
32767, which a negative value identifies dimmer objects and results in larger object 
masks and positive value results in smaller object masks. 
After deciding on the cell identification protocol, there were various assay parameters 
to be set up in order to obtain a precise cell morphology assessment and measurement. 
There were two modes available in the assay parameters, the Basic mode and 
Advanced Mode. Based on the purpose of the experiment to identify and measure 
various morphology features of each cell, assay parameters in basic mode was chosen. 
Assay parameters in basic mode facilitated calculation of the different morphological 
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properties of each object (cell) and target. Multiple general assay parameters 
controlled images processing and analysis, including: 
 Reference well control 
 Units for morphological measurements 
 Object type 
 Background correction 
 Object smoothing 
 Object segmentation 
 Rejecting border objects 
The reference well control parameter is not available in KineticScan HCS Reader, 
thus it was not included in the adjustment and cell characterization can be performed 
using manual level. In  the  identification,  all  images  were  identified  using  “pixel”  as  a  
unit for morphological measurement. Since fluorescence staining was used to label 
the  cells,  the  object  type  “0”  was  used  for  the  potential  images  that  were  brighter  than  
the dark background. Next, background correction is important to prevent 
identification of non-cellular object and reduce the validity of the image analysis. The 
non-cellular background was subtracted  for  each  channel  and  “-1”  value  was  used  to  
perform automated surface fitting and the computed background was subtracted. After 
object identification, two essential parameters were adjusted, which were Object 
Smoothing and Object Segmentation. The Object Smoothing parameter was used to 
smooth or blur the heterogeneous images for easier object border identification. From 
the optimization, poor Object Smoothing led to improper Object Segmentation, thus 
generated unreliable cell identification and measurement (Figure 3.10), which the cell 
was not aligned properly or not identified by the system. 
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Figure 3.10. The faults in cell identification due to incorrect parameter 
values input. Since the value of Object Smoothing and Segmentation 
values were not properly set up, a huge number of cells were not 
identified (orange border), while the identified cells (green border) were 
not properly outlined. 
Object Smoothing   parameter   in   channel   1   for   cell   was   optimized   to   value   “5”   to  
ensure correct identification of cell border and also facilitated proper segmentation 
later on. Due to the mixed population characteristic in the trophoblast lineage, the 
correct Object Segmentation is very important for the software to identify and 
properly resolve single compartment of cell, especially closely neighbored cells. The 
Object Segmentation worked in two ways, which were geometric method and 
intensity method. Since in this differentiation the analysis performed for mixed 
population, it was best to work using intensity method. Finally, all assay parameters 
in the basic mode were thoroughly optimized and summarized in Figure 3.11 for both 










Figure 3.10. The optimized summary of assay parameters value for 
proper both cell-nuclei identification and measurement. 
 
The trophoblast lineage has capability to further differentiation into two major types, 
the single nucleated extravillous cytotrophoblast and multinucleated 
syncytiotrophoblast. Therefore, based on these two trophoblast subtypes, there were 
five morphology features chosen to analyze the trophoblast differentiation and 
potential subtypes emerged from HCS system, which were Total Cell Count, Cell 
Area, Cell Length, Cell Width, Nuclei Count, and Cell-Nuclei Area Differences. The 
analysis carried out by measuring the channel 1 object (cell) and channel 2 member 
(nuclei) fluorescence intensity and assay parameters threshold was applied to generate 
the selected morphology features output value. The intensity-based general input 
features, such as cell/ nuclei size, were input as a gating to separate the cell from 
artifact. 
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Total Cell Count. The number of cells analyzed was reported per well. The value 
represents the average of valid cell identified and counted after applying the object 
selection parameters. 
Cell Area, Length and Width. The cell area is proportional to the total number of 
pixels covered by the object. The measurement of the area, length and width 
(perimeter) of cell were based on the cell bounding box area, which is the rectangle of 
the minimum area that includes the object (Figure 3.12). The final output of the data 
was represented as the average of each feature to the total selected cells for analysis in 





Figure 3.12. The schematic Bounding Box for cell area, length, and width 
measurement. 
 
Nuclei Count. The number of nuclei analyzed within one cell was reported per well. 
The value represents the number of all internal nuclei (member) objects in Channel 2 
within modified Channel 1 cell (object) mask. The final output of the data was 
represented as the average of nuclei number within one cell to the total same feature 
value of selected cells for analysis in the well. 
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Nuclei-Cell Area Differences. This feature relate to how much of the whole cell area 
is taken up by all the nucleis in that object (Figure 3.13). It is defined as difference 
between area of Channel 1 cell (object) and total area of all Channel 2 nuclei 
(member) objects within modified Channel 1 cell (object) mask. The increase in this 
value was resulted from larger total nuclei area within one cell as compared to cell 
area encompassing the total nuclei. The final output of the data was represented as the 
average of number of nuclei within one cell to the total same feature value of selected 







Figure 3.13. The schematic for cell area and nuclei area measurements. 
 
3.5. Selection of growth factor(s)/ cytokine(s) from HCS result 
A total of 11 signaling receptors that were up-regulated during hESC differentiation 







Intensity level + Threshold 
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Fold Change Accession Number Receptor Type Ligand 
CCR7 129 6424.06 NM_001838 Chemokine Chemokine (C-C motif) Ligand 21 (CCL21) 
NTRK2 90 1057.36 NM_001007097 Membrane-bound kinase Brain-Derived Neurotropic Factor (BDNF) 
NR2F2 54 426.64 NM_021005 Hormone-nuclei Retinoic acid (RA) 
CSF3R 36 7448.1 NM_172313 Cytokine Colony stimulating factor 3 (CSF-3/ G-CSF) 
FGFR2 30 2.38 NM_022970 Growth Factor Keratinocyte Growth Factor (KGF) / FGF7 
HGFR 22 25.82 NM_000245 Growth Factor Hepatocyte Growth Factor (HGF) 
EGFR 17 20.98 NM_005228 Growth Factor Epidermal Growth Factor (EGF) 
FOLR1 10 140.09 NM_016729 Membrane-bound protein Folic acid (FA) 
PPARG 8 220.39 NM_138712 Nuclei Prostaglandin J2 (PGJ2) 
CSF2RA 1 34.5 NM_172245 Cytokine Granulocyte Macrophage-Colony Stimulating Factor (GM-CSF) 
BMPR1A 8 0.96 NM_004329 Growth Factor Bone Morphogenic Protein 4 (BMP4) 
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literature studies (Table 3.3). To investigate the effect of each signaling receptor in 
trophoblast lineage further differentiation, a ligand for each corresponding receptor 
were chosen and added into the differentiation media (Figure 3.2(5)). The effect on 
cell morphology then was assessed by HCS system as described previously. Five 
morphology measurements for each signaling molecule treatment were assessed and 
analyzed as compared to untreated. Besides morphology assessment from the HCS 
data, the signaling molecules selection also based on the literature study of each 
signaling receptor and its corresponding ligand. Nevertheless, only limited knowledge 
is available from human system, while animal model and immortalized cell line were 
used as a proxy to investigate the receptors and ligands function. 
CSF3R. Colony Stimulating Factor-3 Receptor is receptor for Granulocyte- Colony 
Stimulating Factor (G-CSF), which is a cytokines that has a role in controlling the 
production, differentiation, and function of granulocytes. Some reports have 
suggested G-CSF role in early gestation at fetal-maternal interface during early 
implantation and throughout the pregnancy, also its receptor expression in trophoblast 
cells (LI et al., 1996; Uzumaki et al., 1989). However, some of the studies done in 
mouse model and very limited information on human system. The CSF3R was 
detected in the stroma of fetal chorionic villi and maternal decidual tissues throughout 
pregnancy by immunostaining with the highest signal during first and third trimester 
of pregnancy (McCracken et al., 1999; Shorter et al., 1992). The stroma cells and 
decidual macrophage were suggested as a source of G-CSF and induce the 
proliferation of trophoblast cells (Miyama et al., 1998). It was also suggested to play 
role in survival of choriocarcinoma trophoblastic cell line through the activation of 
JAK/ STAT and MAPK pathway (Marino and Roguin, 2008).  
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CCR7. Chemokine (C-C motif) receptor 7 is a G protein-coupled receptor that plays 
role in the activation and migration of B and T lymphocytes. This receptor was 
suggested to be involved in immune regulation of uterine environment during embryo 
implantation (Guerin et al., 2011). CCL21 and CCL19 are the specific ligands for this 
receptor. By utilizing CCR7-deficient mice, Teles, et al. (2013) reported the 
involvement of CCR7 by regulating the T-regulator (Treg) cells homing into uterus, 
which is important to prevent the hostile uterine environment. The CCR7+- matured 
Treg cells was reported to induce the expression of TGF-β   in   first   trimester 
trophoblast cell line when co-cultured. It also managed to induce trophoblast cell line 
to recruit iTreg cells in a specific manner, which Treg cells are important in fetal-
maternal immune tolerance (Ramhorst et al., 2012). Nevertheless, the exact and 
complete mechanism is poorly understood in early human embryonic implantation. 
NTRK2. Neurotrophin Tyrosine Kinase Receptor 2 belongs to neurotrophin tyrosine 
kinase receptor family and a member of MAPK signaling pathway. The specific 
ligand for NTRK2 is Brain Derived Neurotrophic Factor (BDNF), which the addition 
of BDNF activates the NTRK2 (TrkB) receptor to promote cell proliferation, 
differentiation and survival in neuronal (Huang and Reichardt, 2003) and non-
neuronal cells, including trophoblast cells (Barbacid, 1994; Ip et al., 1993; Kawamura 
et al., 2009). NTRK2 was reported to be involved in trophoblast cells survival and 
proliferation in mice model (Kawamura et al., 2009). It was also suggested to has a 
role in cytotrophoblast proliferation and differentiation in in vivo animal model of 
ectopic pregnancy, where the inhibition of NTRK2 decreased the extravillous 
trophoblast marker and chorionic gonadotrophin (Kawamura et al., 2011). 
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NR2F2. Nuclei Receptor subfamily 2, group F, member 2, also known as COUPTFII 
is a previously known as orphan nuclei receptor until retinoic acid was reported as its 
only known specific ligand (Kruse et al., 2008). There is very limited information 
regarding this receptor involvement in human placentation and embryonic 
implantation. By utilizing NR2F2-knockout mice model, it was reported that the 
deletion of NR2F2 in uterus led to placentation deficiency, which suggested the 
involvement of NR2F2 in placenta development (Petit et al., 2007). Retinoic acid is 
also known to induce transcription factor TFAP2A, which is an important 
transcriptional regulator in trophoblast lineage differentiation (Cheng et al., 2004). 
Moreover, TFAP2A were suggested to have critical role in regulating the human 
Placental Lactogen (hPL) gene (Richardson et al., 2000). In choriocarcinoma cell line, 
TFAP2A was also reported to be involved in the regulation of basal and cAMP-
induced hCG expression (LiCalsi et al., 2000). Thus, it was suggested that NR2F2 
plays a role in the trophoblast differentiation, which modulates the induction of 
TFAP2A by retinoic acid (Hubert et al., 2010). 
PPARG. Peroxisome Proliferator-Activated Receptor Gamma is a member of the 
peroxisome proliferator-activated receptor (PPAR) subfamily of nuclei hormone 
receptors. It forms dimer with Retinoid X-Receptors (RXRs) to regulate certain genes 
(Kliewer et al., 1992). It is a ligand-inducible transcription factor with 15-Deoxy-
12,14-prostaglandin J2 (PGJ2) as its corresponding ligand (Forman et al., 1995). It 
was reported as one of the factors that is required in cardiac, adipose, and placental 
development, which is based on the PPARG deletion in mice model demonstrated that 
it is indispensible for proper functioning placenta (Barak et al., 1999) and trophoblast 
differentiation (Tarrade et al., 2001). By using first trimester extravillous trophoblast 
samples, it was also suggested to hold an important role in extravillous 
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cytotrophoblast invasiveness and metabolic condition during fetal development 
(Waite et al., 2000). 
FOLR1. Folate Receptor 1 is a member of folate receptor family and binds folate and 
its derivatives, also known to be expressed in the placenta (Antony et al., 1981; 
Whetstine et al., 2002). Folic acid is one of the essential nutrition during pregnancy 
and deficiency of folic acid is known to cause various metabolic diseases and 
especially the failure in neural tube closure of spina bifida, however nothing is known 
regarding its cellular and molecular mechanism (Araújo et al., 2013; Green, 2002; 
Steegers-Theunissen et al., 2013). Folic acid was suggested to possibly play role in 
affecting extravillous trophoblast invasiveness and early placental development 
(Williams et al., 2011). It was suggested to be involved in folate metabolism and 
transport 5-methyltetrahydrofolate into the cells, which acted as methyl donor in 
homocysteine metabolism for possibly certain DNA methylation. The receptor was 
also expressed on the membrane of first and third trimester syncytiotrophoblast (Di 
Simone et al., 2004; Hempstock et al., 2004; Lala et al., 1998) (Enders and King, 
1988; Luckett, 1978; Solanky et al., 2010). 
EGFR. Epidermal Growth Factor Receptor is a transmembrane glycoprotein that 
belongs to tyrosine kinase superfamily. There are various ligands to bind EGFR, such 
as Epidermal Growth Factor (EGF), Heparin-Binding Epidermal Growth Factor (Hb-
EGF) and Transforming Growth Factor Alpha (TGF-α).   EGFR   and   its   ligand   EGF  
were expressed in the endometrium by immunohistochemical localization 
(Hempstock et al., 2004; Hofmann et al., 1991). The EGF was reported as one of the 
factors secreted from the decidua and had a role in the proliferation of extravillous 
trophoblast in vitro (Lala et al., 1998). However, based on the EGF treatment on 
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placenta explants that were collected from two early stages, 4-5 weeks and 6-12 
weeks, EGF were reported to have two distinct effects, which induced proliferation of 
earlier stages trophoblast and differentiation by hCG and human Placenta Lactogen 
(hPL) secretion of later stage trophoblast (Maruo et al., 1992). 
FGFR2b. Fibroblast Growth Factor Receptor 2 isoform b is a member of fibroblast 
growth factor family that contains a cytoplasmic tyrosine kinase domain. The specific 
ligand for FGFR2b receptor is Keratinocyte Growth Factor (KGF) or FGF7 (Miki et 
al., 1992; Ornitz et al., 1996). Little is known about the function of FGFR2b and 
FGF7 regarding early embryonic implantation in human. Koji, et al.(1994) reported 
FGF7 mRNA expression in the primate endometrium. The FGF7 and its receptor also 
reported to be expressed in the human endometrium and chorionic villi, suggesting its 
biological significance in decidual-trophoblast interaction during early pregnancy in 
human (Matsui et al., 1997; 2000). It was also thought to affect trophoblast 
differentiation by modulating PLAC1, which is one of the placenta-specific genes that 
was suggested to play role in trophoblast growth, differentiation, and function (Fant et 
al., 2002; Massabbal et al., 2005).   Interestingly,   we   observed   an   “isoform   switch”  
from FGFR2c to FGFR2b by analyzing from our lab available mRNA seq data of H1 
differentiation towards trophoblast lineage (Figure 3.14), which with differentiation 
progression towards the trophoblast lineage, the expression of FGFR2c is decreasing 
together with the elevation of FGFR2b expression. This isomer switch coincides with 
the fact that even though both isomer FGFR2c and FGFR2b are mutually exclusively 
expressed; the FGFR2c is generally expressed in mesenchymal cells, while the 
FGFR2b is restricted to epithelial cells (trophoblast cells) (Cha et al., 2008). 
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Figure 3.14. The Isoform switch of FGFR2 in H1 differentiation towards 
trophoblast lineage. The figure was obtained and analyzed from the 
available mRNA-seq  data   in  Dr.  Robson’s   lab   (mRNA-seq was done by 
Wishva H.B.).  
CSF2R. Colony Stimulating Factor Receptor 2 is a member of cytokine family 
receptor. It is a heterodimeric receptor for CSF2 or Granulocyte-Macrophage Colony 
Stimulating Factor (GMCSF), which controls production, differentiation, and function 







FGFR2 IIIB   
chr10:123,264,271-123,270,113 (5,843 bp) 
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aberrant expression of GMCSF was reported in the pre-eclamptic women, thus it was 
suggested as one of the regulators in early pathogenesis of pre-eclampsia (Huang et 
al., 2010). The glandular epithelium was reported to produce GM-CSF in human 
endometrium  with   peak   during   “window   of   implantation”   (Giacomini et al., 1995; 
Robertson et al., 1992). The GM-CSF presence was also reported not only by 
epithelial cells, but also by endometrial cells (Sharpe-Timms et al., 1994), a fallopian 
tubes (Zhao and Chegini, 1994), and human first trimester trophoblast explant (Jokhi 
et al., 1994). It was also suggested as one of the factors to affect the development and 
function of placenta, for example was to induce syncytium formation of term villous 
cytotrophoblast (Bowen et al., 2002; Morrish et al., 1998).    
HGFR. Hepatocyte Growth Factor Receptor is a protein encoded by proto-oncogene 
MET and encodes tyrosine kinase activity (Park et al., 1987; Tsarfaty et al., 1992). 
HGF as a specific ligand for this receptor has multiple roles, such as promoting 
growth, differentiation, invasion, and morphogenesis (Montesano et al., 1997; 
Niranjan et al., 1995; Soriano et al., 1995). The placenta was reported as the richest 
source for HGF, where the mRNA of HGF strongly detected at villous mesenchymal 
core (Jin et al., 1993). Saito, et al. (1995) suggested HGF as a potent mitogen of 
trophoblast, which increased the proliferation but not a placental differentiation factor. 
Moreover, from in vitro studies, HGF was described to induce the invasiveness of 
trophoblast cells during first and second trimester under Transforming Growth Factor 
I (TGFBI) regulation and the gene alteration provided insight into the abnormal 
placentation in pre-eclampsia (Kauma et al., 1999; Nasu et al., 2000; Tse et al., 2002). 
BMPRI. Bone Morphogenic Protein Receptor 1 is a member of transmembrane 
serine/ threonine kinases that has two types, which are BMPRIA and BMPRIB. One 
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of the corresponding ligands for BMPRI receptor is BMP4, which is also a member of 
TGFB superfamily. BMP4 has been known as one of major factors to generate 
trophoblast lineage from human pluripotent stem cell in vitro. However, the real 
function of BMP4 and the mechanism in deriving trophoblast lineage remains 
elucidated in vivo. Different effects observed between single and combination 
treatment of BMP4 in hESC differentiation towards trophoblast lineage. Xu, et 
al.(2002) firstly reported the involvement of BMP4 to derive trophoblast lineage from 
hESC (H1, H7, and H9), which was worked in dose-dependent manner that resulted 
in epithelial-like morphology and expressed trophoblast lineage markers with 
nonetheless, other lineage markers, such as primitive and definitive endodermal 
markers, at least during initial time points (Das et al., 2007; Marchand et al., 2011; Yu 
et al., 2011). Since the FGF2 is an important factor that maintains the hESC 
pluripotency and presents in hESC growth media, when added with BMP4, it did 
slower the differentiation (Schulz et al., 2008). Therefore, inhibition of FGF2 by 
adding FGF-signaling inhibitor, such as SU5402 (Katoh and Katoh, 2009) and 
combined with proper concentration of BMP4 were reported to more efficiently 
generate trophoblast lineage (Sudheer et al., 2012; Yu et al., 2011). On the other hand, 
BMP4 treatment in hESC culture combined with high presence of FGF2 (bFGF) 
generated mesoderm lineage, instead of trophoblast lineage (Bernardo et al., 2011).            
 
Figure 3.15. Summary of quantitative and qualitative results of HCS for 
each signaling molecule and combination on H1-differentiated 
trophoblast culture treatment (a) – (n). From the HCS system, all of the 
quantitative data are presented in graphs and for each treatment, 
several fields were taken as representative for overall two biological 
replicates. All of results were taken from 72 hours of treatments. 
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(k)                                        BMP4 – 72H 
 
   
 



























































(l)                                     BMP4 + EGF – 72H 
 
   
 




























































(m)                                    BMP4 + FGF7 – 72H 
   
 



























































(n)                                  BMP4 + EGF + FGF7 – 72H 
   
 























































From the RNA-seq data of the H1 differentiation towards trophoblast lineage and 
comparison with literature studies, eleven signaling molecule receptors were chosen. 
A ligand for each of the receptor was chosen and added in the culture growth media 
(Baczyk, et al. (2009) in three different concentrations (10 ng/ml, 50 ng/ml, and 100 
ng/ml) to observe the effect on the H1-differentiated trophoblast culture. The purpose 
of HCS experiments is to screen any potential ligand(s) that might induce trophoblast 
subtypes formation by observation on significant changes of morphology features. 
Based on the morphology observation on the earlier time points, 24 hours and 48 
hours, there were no significant differences as compared to untreated control (Figure 
3.16(a)-(b)) and the variation between replicates were very big (complete data not 
shown), thus the cultures that were treated up to 72 hours were chosen for further 
analysis.  
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Figure 3.16. Representative quantitative measurement of morphology 
features from 24 hours (a) and 48 hours (b) signaling molecules 
treatment.  
 
As can be seen from the morphology quantitative measurement from HCS system 
(Figure 3.15), some signaling molecules showed morphological features differences 
as compared to the untreated control. The H1-differentiated trophoblast culture that 
were treated with EGF for 72 hours showed differences in morphological features as 
compared with untreated control with 100ng/ml exhibits the most value differences 
(Figure 3.15 (g)). In comparison with the untreated control, the EGF-treated culture 
showed around 40% lower cell count value with 35% higher cells area value, 20% 
higher nuclei number, and 35% higher nuclei-cell area ratio, means there was a 
possibility of cells fusion, which characterized by increase in nuclear-cell count ratio, 
cells size (area), low or no cell proliferation, and higher ratio of total nuclei area to 
cell area. The similar pattern of morphology features was also observed in the culture 


































value of nuclei number was observed (Figure 3.15 (h)). On the other hand, several 
other signaling molecules, such as G-CSF, CCL21, BDNF, GM-CSF, and HGF the 
morphology features values only showed small differences, which were less than 20% 
for overall morphology features values as compared to untreated control, which were 
excluded for future experiments (Figure 3.15.(a-c)). The cultures treated with RA, 
PGJ-2, and FA also showed no significant differences in the morphological features 
values and even with decrease cell count value, which is a sign of cell death (Figure 
3.15.(d-f)). For the BMP4-treated culture, only small differences of the morphological 
features values were observed. However, as one of the major driving factors in the 
trophoblast lineage derivation, BMP4 was included in the shortlisted factors for 
further analysis. In summary, based on quantitative and qualitative results of the HCS 
signaling molecules screening to investigate various trophoblast subtypes, the data 
showed the multinucleated trophoblast features or syncytiotrophoblast that came out 
as the most prominent cell type from the culture.  
From the first HCS screening to analyze the effect of each signaling molecule 
treatment, three out of eleven signaling molecules caused the similar pattern changes 
of morphological features, which supported the formation of syncytiotrophoblast. 
Therefore, to increase the efficiency of the differentiation, three selected signaling 
molecules, which were EGF, FGF7, and BMP4 were combined to increase the 
syncytiotrophoblast formation. To optimize the combination of the selected signaling 
molecule, each of EGF and FGF7 was combined with BMP4, since it is known as 
main factor to induce trophoblast lineage from hESC in vitro. From the comparison 
between quantitative graphs of all three combinations (BMP4-EGF, BMP4-FGF7, 
BMP4-EGF-FGF7), the final combination of all three selected signaling molecules 
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exhibited the highest number of syncytiotrophoblast formation (Figure 3.15(n)). Thus, 


















Confocal microscopy. After the selection and combination of signaling molecules 
from the HCS screening that induced the formation of syncytiotrophoblast, various 
downstream experiments were done to validate the culture differentiation. First of all, 
the quantification of syncytiotrophoblast was validated using immunofluorescence 
staining and confocal microscopy. In the HCS system, the cell was labeled with whole 
cell stain that stains cell entire cytoplasm along with nucleus, which enabled the 
detection by the systems. Since the cell identification was based on the fluorescence 
intensity, there might be a problem when the neighboring cells stuck together or 
overlap with each other, which might be difficult for the software to identify the cell 
boundary. Therefore, validation of fusion quantification using another method was 
necessary to be done.  
One of the common methods to quantify the cell fusion, especially for trophoblast 
fusion to form syncytiotrophoblast, was the immunofluorescence counter-staining 
using cell membrane dye and nucleus dye, which was followed by visualization and 
manual counting using confocal microscope. This method has been commonly used to 
identify and quantify the syncytiotrophoblast formation (Baczyk et al., 2009; Black et 
al., 2004; Goldman-Wohl et al., 2013; Sudheer et al., 2012). Chang, et al. (2011) used 
the similar immunostaining protocol to identify and measure the fusion rate of GCM1 
knockdown BeWo choriocarcinoma cell line by combination of Desmoplakin 
membrane stain and DAPI nucleus stain, also visualization using confocal microscopy. 
In this protocol, the membrane staining, for example using E-Cadherin or 
Desmoplakin was used to enable the clear identification of cell boundary, while the 
nucleus stain facilitate the quantification of nucleus inside one compartment of cell. 
The main advantage of confocal microscope in this method, beside to generate clearer 
images as compared to normal or fixed fluorescence microscope, is the ability to 
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capture the image in different focal planes and presented in multiple image stacks, 
which enables better identification of overlapping cells in the crowded culture.  
In this experiment, the H1 cells were cultured and differentiated towards trophoblast 
lineage and subsequently treated with combination of selected signaling molecules 
from HCS screening, which were each 100ng/ml of BMP4, EGF, and FGF7, for 72 
hours. The culture then was fixed and stained with membrane and nucleus dye, E-
Cadherin and DAPI, respectively. The stained culture was then visualized using 
confocal microscope and the fusion rate was quantified according to the standard 
protocol. 
 
Figure 4.1. The fusion rates measurement by confocal microscopy. The 
cultures were treated with BMP4 and combination of BMP4+EGF+FGF7 
for 72 hours. The untreated culture was used as a control.  
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The measurements were made and summarized from three independent biological 
replicates. As can be seen on Figure 4.1, the H1-differentiated trophoblast culture that 
was treated with only BMP4 showed around 70% of syncytiotrophoblast formation, 
and the combination three selected signaling molecules exhibited better syncytial 
formation, which is around 90% from the population. During counting, the cell that 
contains more than two nuclei was considered a syncytiotrophoblast Figure 4.2. The 
identification and measurement were done in a very detailed way by going through all 
layers of each confocal image, thus minimized the false positive and negative.  
       (UNTREATED)                        (BMP4)                    (BMP4+EGF+FGF7)           
 
Figure 4.2. Representative confocal microscope images of each 
treatment for fusion rate quantification.  
From the Figure 4.2, there is high formation of syncytiotrophoblast from the H1-
differentiated trophoblast culture, which was treated with BMP4, with some single-
nucleated trophoblast cells observed. Even more syncytiotrophoblast formation were 
observed from the culture that was treated with combination of BMP4, EGF, and 
FGF7, while in the untreated control, there was only few syncytial formations. In the 
staining, the morphology of syncytiotrophoblast that was multi-nucleated was easily 
distinguished from other trophoblast cells. From the image, the single-nucleus 
trophoblast cells had a very defined E-Cadherin membrane staining with a relatively 
normal nucleus size. On the other hand, the syncytiotrophoblast or multi-nucleuses 
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cells showed a diminished or partial membrane staining with various and relatively 
big nucleus sizes (Figure 4.2). Besides the multinucleated properties, the 
disappearance of membrane staining and variation in nucleus size have also been used 
to determine the syncytiotrophoblast existence or formation (Al-Nasiry et al., 2006; 
Frendo et al., 2003). Similar reduced or disappearance of e-cadherin staining was 
detected in the BMP4 and combination of BMP4, EGF, and FGF7 treated culture, 
which marked the existence of syncytiotrophoblast. This phenomenon in 
syncytiotrophoblast was suggested based on BeWo choriocarcinoma cells study, 
which the disappearance of E-cadherin during syncytialization was possibly caused 
by reduction of cell adhesion molecules by cAMP-mediated down regulation of E-
cadherin mRNA (Alsat et al., 1996; Coutifaris et al., 1991; Douglas and King, 1990). 
The recent review discussed about the involvement of cells size and intracellular 
components involvement in affecting nucleus size and shape (Edens et al., 2013). 
From yeast model to study cytoplasmic-nucleus ratio, it was reported that nucleus 
surrounded by large proportion of cytoplasmic volume has larger size as compared to 
the one in smaller cytoplasmic volume (Neumann and Nurse, 2007). Same effect also 
observed in Drosophila and HeLa cells-injected Xenopus model that were exposed to 
mutation that affect cells growth and size, which suggested the involvement of 
nucleocytoplasmic transport in regulating the nucleus volume (Goehring and Hyman, 
2012; Gurdon, 1976; Tapon et al., 2001). As also shown on Figure 4.2, the 
enlargement of nucleus size was also observed in the cells that already fused in the 




Measurement of human chorionic-gonadotrophin (hCG) production. Another 
validation of syncytial formation is the measurement of human Chorionic-
Gonadotrophin (hCG) hormone. As known before, one of the most important 
hormones and is produced during pregnancy is human chorionic-gonadotrophin, 
which is also used as indicator in commercialized pregnancy test apparatus (Birken et 
al., 1996; Cole et al., 2011). Various functions of hCG during pregnancy have been 
reported, such as promotion of progesterone production from corpus luteum (Schmitt 
et al., 1996), blockage of phagocytosis and immune-suppression of invading 
trophoblast cells (Schumacher et al., 2009; Wan et al., 2007), involvement in placenta 
growth and development (Rao et al., 1993), also differentiation of cytotrophoblast 
(Cronier et al., 1994; Shi et al., 1993). From choriocarcinoma cell line study, it was 
reported that syncytiotrophoblast and villous cytotrophoblast acted as a primary 
source of hCG production (Kovalevskaya et al., 2002).  
Since multinucleated syncytiotrophoblast is known to secrete hCG, the measurement 
of hCG hormone was performed to further functionally validate the syncytial 
formation in the signaling molecules-treated culture. The culture media that was used 
to further differentiate H1-differentiated trophoblast was confirmed to not contain any 
hCG, thus the hCG that was detected should be from the syncytiotrophoblast secretion 
and prevented any false positive from pre-existing hCG. The culture media was 
collected from each three different time points and each two different treatments with 
untreated culture as a control. The culture media samples were sent for total hCG 
measurement. The summary of results is presented in a graph as shown on Figure 4.3.    
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Figure 4.3. The total hCG measurement from 24, 48, and 72 hours of 
treated and untreated culture. The cultures were treated with BMP4 and 
combination of BMP4+EGF+FGF7 (BEF). The untreated culture was used 
as a control. 
 
As can be seen in Figure 4.3, there were almost no differences of hCG production 
between the BMP4-treated culture and BEF-treated culture, even as both compared to 
the untreated culture, from 24 hours culture. Along with the treatment progression, the 
hCG secretion from both treated and untreated control started to rise up at 48 hours 
for around 10 folds and peaked at 72 hours for 100 folds, as compared to the first time 
point. There were small or almost no differences observed between treated and 
untreated culture from the two initial time points, which were 24 and 48 hours. 
However, from the 72 hours culture, there were significant differences between the 
treated and untreated culture, which in the treated culture, the hCG secretion reached 
around 40,000 IU/L as shown on the Figure 4.3. In summary, based on the hCG 
secretion, more syncytiotrophoblast or its precursor presented in the culture that was 
treated with combination of BMP4. EGF, and FGF7. As previously described, the 
hCG was known to be produced by syncytiotrophoblast and also by cytotrophoblast 

















which explains the elevation of hCG secretion also observed in the other treatment at 
much lower level. Therefore, hCG secretion measurement result should be taken as a 
further validation to the morphological data, such as confocal microscopy-based 
fusion measurement, which has already done previously in this experiment.    
The validation of syncytiotrophoblast markers. The next validation for the 
syncytiotrophoblast formation is the detection of various cellular markers at protein 
level, such as immunofluorescence staining and western blot. The cultures treated 
with signaling molecule BMP4 and combination of BMP4-EGF-FGF7 for 72 hours 
were fixed and stained with several known cytotrophoblast and syncytiotrophoblast 
markers. The same staining was also performed on the untreated control, which was 
H1-differentiated trophoblast that was grown along with the treated culture and fed 
with only basal media (Baczyk’s  media) without any addition of signaling molecule. 
One of the specific markers for cytotrophoblast and syncytiotrophoblast is Glial 
Missing Cell -1 (GCM1) transcription factor that is a mammalian homolog of GCM 
and is expressed in placenta, kidney, and thymus (Günther et al., 2000; 
Hashemolhosseini et al., 2002; Nait-Oumesmar et al., 2000). GCM1 is known as an 
important regulator in syncytiotrophoblast fusion event (Chang et al., 2011; Yu et al., 
2002). In BeWo choriocarcinoma cell line, the knock down of GCM-1 led to 
diminished intercellular fusion in the cells. By utilizing choriocarcinoma cell line 
BeWo that induced with forskolin or cAMP to form syncytiotrophoblast, it was 
reported that the GCM-1 was up-regulated through PKA pathway stimulation (Knerr 
et al., 2005; Lin et al., 2005). The immunostaining was done to check the GCM1 
marker expression in this trophoblast differentiation to syncytiotrophoblast. As a 
transcription factor, GCM1 was expressed in the cell nucleus. From the Figure 4.4, 
the GCM1 were localized in the cell nucleus both in the 27 hours BMP4-treated and 
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BEF-treated culture, also it was expressed in the untreated control culture. The GCM1 
expression both in treated and untreated culture was expected, as the untreated control 
also from the H1-differentiated trophoblast and the GCM1 expression most possibly 
was resulted from unspecific spontaneous further differentiation. 
                              BMP4          BEF 
                            
                    UNTREATED                             SBD3-CONTROL 
                            
Figure 4.4. The GCM1 immunofluorescence staining on 72 hours of 
treated and untreated culture. The treated culture were consisted of 
BMP4-treated and combination BEF treatment. 
 
Another essential marker besides GCM-1 that was expressed in cytotrophoblast is 
Cytokeratin-7. Several cytokeratin expressions were identified in human term 
trophoblast explant, such as Cyokeratin-7, Cytokeratin-17 and Cytokeratin-8/18, 
which the expression was related to the trophoblast subpopulation (Daya and Sabet, 
1991; Mühlhauser et al., 1995; Pröll et al., 1997). Since the other cytokeratins stained 
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not only trophoblast cells but also endometrial and stromal cells (Haigh et al., 1999), 
several studies have reported the cytokeratin-7 as specific marker for first trimester 
trophoblast explant, thus used as a marker in the first trimester cytotrophoblast 
purification protocol (Maldonado-Estrada et al., 2004; Pötgens et al., 2003).   
                          BMP4                   BEF 
                          
                    UNTREATED                           SBD3-CONTROL 
                          
Figure 4.5. The Cytokeratin-7 (green) immunofluorescence staining on 
72 hours of treated and untreated culture. The treated culture were 
consisted of BMP4-treated and combination BEF treatment. DAPI 
nucleus counter-staining was performed (blue). 
 
The cytokeratin-7 staining was performed on the signaling molecules-treated 72 hours 
culture. The untreated culture and SB-treated day 3 were used as control in the 
staining experiment. As shown on Figure 4.5, the cytokeratin-7 expression was 
present in treated and untreated cultures. In the BMP4-treated culture and BEF-treated 
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culture, there were cytoskeleton rearrangement and expansion in the fused 
syncytiotrophoblast cells, which characterized by multiple nucleuses. On the other 
hand, in the untreated culture, the expression of cytokeratin-7 still present in the 
culture, however the cytoskeleton encased mostly only one nucleus. Thus, these 
evidences suggest the syncytiotrophoblast derived from this differentiation could 
possibly be compared to the one from early first trimester, as cytokeratin-7 was 
reported as specific marker for first trimester cytotrophoblast (Blaschitz et al., 2000; 
Pötgens et al., 2003).   
Since little is known about the fusion mechanism of human syncytiotrophoblast, only 
few fusion markers are commonly used. Among various retroviral elements that were 
identified in human genome, there are two well-known retrotransposon elements that 
were suggested to play a role in human placentation, namely Human Endogenous 
RetroViruses-W1 (HERV-W1) or Syncytin-1 and HERV-FRD or Syncytin-2 (de 
Parseval et al., 2003; Villesen et al., 2004). Both of the factors are known as 
downstream target and regulated by transcription factor GCM1. Syncytin-1 is a full-
length envelope product that is encoded by provirus ERVWE1, which the trans-
membrane (TM) domain is responsible for induction of cell-cell fusion during 
differentiation of syncytiotrophoblast in placenta (Blond et al., 2000; Mi et al., 2000). 
The syncytin-1 was reported to bind to the human sodium-dependent neutral amino 
acid transporters hASCT1 and hASCT2, which was suggested as the first step of a 
complex cell fusion process (Lavillette et al., 2002). The down-regulated syncytin-1 
expression was detected in the pre-eclampsia placental explant, which suggested the 
importance of syncytin-1 as one of factors in normal placentation (Lee et al., 2001). 
Another member of retrotransposon that was expressed in the placenta is Syncytin-2, 
which was encoded by provirus ERVFRDE1. Besides specifically was expressed in 
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the placenta, Syncytin-2 also showed fusogenic or fusion inducer activity (Esnault et 
al., 2008), which through the dependence of carbohydrate transducer MSFD2 (Vargas 
et al., 2009), and was reported to be conserved in mammalian evolution (Blaise et al., 
2003). The syncytin-2 was suggested to have immunosuppressive role in placental 
development and eclamptic disorder in pregnancy (Mangeney et al., 2007). In this 
experiment, the immunostaining of syncytin-1 was performed to check the expression 
on the signaling molecules-treated culture. The immunostaining of syncytin-2 was 
performed. As can be seen in Figure 4.6, the syncytin-1 expression located at the 
cytoplasmic region of syncytiotrophoblast. In comparison between all treatments, the 
highest expression of syncytin-1 was observed in the culture that was treated with 
BEF combination as compared to BMP4-treated culture and untreated control. The 
expression of syncytin -1 was not detected in the day 0 trophoblast progenitor culture 
and pluripotent H1 cells as negative control. The same pattern was observed for 
syncytin-2 expression (Figure 4.7), which the highest expression was detected in the 
culture that was treated with BEF combination for 72 hours.  
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Figure 4.6. The SYNCYTIN-1 immunofluorescence staining on 72 hours 
of treated and untreated culture. The treated culture were consisted of 
BMP4-treated and combination BEF treatment. The day 0 trophoblast 


















Figure 4.7. The SYNCYTIN-2 immunofluorescence staining on 72 hours 
of treated and untreated culture. The treated culture were consisted of 
BMP4-treated and combination BEF treatment. The pluripotent H1 were 
used as another controls. 
 
From the HCS and immunofluorescence-based validation, the combination of BMP4, 
EGF, and FGF7 treatment had generated the highest percentage of syncytial 
formation. As already described through the series of early implanted human 
embryonic section and early embryonic implantation study in non-human primate 
(macaque monkey), multinucleated syncytiotrophoblast cells were seen at the front 
line with maternal decidua (Heuser & Streeter, 1941; Hamilton, et al., 1943). These 
observations suggested that the early syncytiotrophoblast has invasive characteristic 
and might play important roles in invading the maternal endometrium to properly 
attach and embed the embryo into the uterine wall. In the macaque monkey study, the 
group of multinucleated cells resembling the formation of Collective Cell Invasion 
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(CCI), which is one of the invasive features of metastatic cancer cells. One of the 
major markers of metastatic event is the expression of Membrane-associated Type-1-
Matrix Metallo-Proteinase (MT1-MMP) or MMP-14. Therefore, by referring to the 
available RNA-seq data of H1-differentiated trophoblast cells, the expression of 
MMP-14 was investigated. The MMP-14 expression was ranked within top 500 genes 
that were up regulated from H1 differentiation towards trophoblast lineage using SB 
treatment. In comparison with other MMPs, such as MMP-2 and MMP-9, the 
expression of MMP-14 has the highest RPKM value (Figure 4.7). 
                  
Figure 4.8. The RPKM values comparison between MMP-14 with MMP-2 
and MMP-9 in H1-differentiated trophoblast culture. The RNA-
sequencing was performed using H1-differentiated trophoblast culture 
that was treated with SB up to 8 days. 
 
Based on those observations, MT1-MMP immunofluorescence staining and western 
blot were performed for 72 hours BMP4-treated and BEF-treated cultures to check its 
expression in syncytiotrophoblast.    
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Figure 4.9. The MT1-MMP (MMP14) immunofluorescence staining on 72 
hours of treated and untreated culture. The treated culture were 
consisted of BMP4-treated and combination BEF treatment. 
 
As shown in Figure 4.9, the MMP-14 was significantly expressed in the BEF-treated 
culture and BMP4-treated culture, which is commonly localized and distributed 
within cytoplasm of syncytial compartment and not the single-nucleated cell. The 
MMP-14 was also slightly detected in the untreated control, but completely absent in 
72 hours SB-treated or day 0 culture. The MMP-14 antibody that targets catalytic 
domain, which exists in active form, was used in the immunofluorescence staining. 
Since, the MT1-MMP exists in various forms, including active (52kD) and inactive 
(60kD), western blot was performed to detect the multiple forms of MMP-14 (Ra and 
Parks, 2007).  
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Figure 4.10. The MT1-MMP (MMP14) western blot detection of 24 to 72 
hours of treated culture. The treated culture were consisted of BMP4-
treated and combination BEF treatment. The untreated culture and day 3 
SB-treated cultures were used as a control. GAPDH was used as a 
loading control. 
 
From western blot validation, several sizes of band were detected (Figure 4.10). As 
observed on the figure, in the SB day 3-treated culture only two types of band were 
detected, which were inactive form (63kD) and further degraded inactive form (42kD). 
While in the treated culture, both BMP4-treated and BEF-treated, three types of band 
were seen, which were inactive form (63kD), active form (54kD), and further 
degraded inactive form (42kD). Based on the time point observations in the figure, the 
MMP-14 inactive form that was first very intense in the day 3 SB (Day 0) control and 
24 hours BMP4-treated culture, which then it weakened in the treated culture along 
time progression. On the other hand, the MT1-MMP active form was very faint in the 
SB-treated day 3 culture and was getting stronger along the time points. Nevertheless, 
further degraded inactive MT1-MMP form was detected in all of the treated cultures, 
and the MT1-MMP active form was detected in the untreated control culture. This 
phenomenon might be caused by the existing invasive syncytiotrophoblast from 
unspecific and spontaneous differentiation of trophoblast cells in untreated control. In 
comparison with the immunofluorescence staining of MT1-MMP catalytic domain, 





might need to be repeated with modification in sample preparation, such as separation 
of cellular membrane from cytoplasm or other cellular part. Thus the membrane 
protein isolation and purification will increase the intensity and validity of MT1-
MMP active form, which exists as membrane-bound protein. 
As reported in the literature, the general characteristic of cancer cell undergoing 
metastatic is the formation of complex involving actin cytoskeleton rearrangement 
with major marker MT1-MMP localization  to  the  “leg”  of  F-actin cytoskeleton, which 
is called Invadopodia (-podia = leg) (Poincloux et al., 2009; Watanabe et al., 2013). 
Therefore, to investigate the existence of invadopodia complex formation in the 
invasive syncytiotrophoblast, the immunofluorescence counter-staining of phalloidin-
conjugated F-actin with MT1-MMP antibody was performed. 
               
Figure 4.11. The identification of Invadopodia complex formation in 
syncytiotrophoblast from 72 hours BEF-treated culture. The 488 
phalloidin-conjugated F-actin were used to detect actin cytoskeleton 
(green), which counter-stained with MMP-14 antibody (red) and DAPI as 
nuclei stain (blue). 
 
From Figure 4.11, the F-actin cytoskeleton rearrangement can be seen forming 
several focal points with MT1-MMP concentrated at the F-actin leg. Moreover, it is 
interesting that the invadopodia complex contains multiple nuclei, which shows the 
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invasive potential in the syncytiotrophoblast from 72 hours BEF-treated culture. In 
summary, the BEF-treated culture as compared to BMP4-treated culture with day 3 
SB-treated and untreated cultures as a control, has the highest syncytiotrophoblast 
formation as quantified by HCS system and validated with immunostaining-confocal 
microscopy measurement. The syncytiotrophoblast major markers, such as GCM-1 
and Syncytin-1 also shown to be expressed in the BEF-treated culture from 
immunofluorescence staining validation, which confirmed the identity of 
syncytiotrophoblast cells. Finally, the potential of invasive properties in 
syncytiotrophoblast were described by positive immunostaining of major components 
of invadopodia, such as MT1-MMP expression and F-actin cytoskeleton 











5.1. Signaling Molecules in Invasive Syncytiotrophoblast Formation 
The capacity of hESC to differentiate into various types of cell belong to all three 
germ layer (Pera et al., 2000; Vazin and Freed, 2010), especially extraembryonic 
tissue trophoblast lineage, has generate a potential model to study placentation during 
early embryonic implantation in human (Pera and Trounson, 2004; Schulz et al., 
2008). Firstly, in order to investigate the capacity of human pluripotent stem cells 
(hESC/ hESC) to generate trophoblast lineage cell types, especially the ones from 
early embryonic implantation, H1 hESC cell line was used and differentiated towards 
trophoblast lineage. Various methods have been established to generate trophoblast 
lineage from hESC and the Bone Morphogenetic Protein 4 (BMP4) has been regarded 
as an essential molecule to induce the differentiation (Amita et al., 2013; Xu et al., 
2002). The differentiation protocol that is established in our lab is utilizing the 
combination of BMP4 and small molecules SU5402 (SB treatment). BMP4 is a 
member of bone morphogenetic protein family and roles in BMP signaling, which is 
also a part of TGF-β signaling pathway (Derynck & Miyazono, 2008). The BMP 
signaling can be activated by various receptors, which can be divided into two major 
groups, receptor type-1 and receptors type-2 (Dijke et al., 1996). Eventhough both 
receptors are required for signal transduction, BMP4 is known to bind the type-1 
receptor (BMPR-1), which has two different subtypes, BMPR-1A and BMPR-2A 
(Dijke et al., 1994). The BMP4 activates the signal transduction through SMAD-1/5/8 
receptors phosphorylation for signal translocation into nucleus and regulates the target 
genes expression (Chen and Massagué, 1999; Kretzschmar and Massagué, 1998). 
Another molecule added into the protocol is SU5402, which is a FGF-signaling 
inhibitor (Simon, 2000). As known before, FGF signaling pathways is one of the 
essential pathways in establishing the undifferentiated state of hPS cells (Ding et al., 
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2010; Eiselleova et al., 2009), thus the addition of FGF signaling inhibitor supports 
the BMP signaling in directing the differentiation towards trophoblast lineage (Katoh 
and Katoh, 2009; Sudheer et al., 2012). From our initial differentiation of H1 towards 
trophoblast lineage using combination treatment of BMP4 and SU5402 in 
unconditioned hESC media, there were morphological changes observed that resulted 
in flattened and sparse epithelial-like cells, which are similar to reported trophoblast 
morphology features (Schulz et al., 2008). Since the differentiation took place 
gradually from periphery towards the center of the colony (Das et al., 2007), the 72 
hours treatment was made in order to ensure the complete differentiation throughout 
colony. Any cells that are still in undifferentiated stages might result in the misleading 
differentiation if were treated with certain signaling molecules in the subsequent 
differentiation. For example, the Brain-Derived Neurotrophic Factor (BDNF) 
treatment on hESC supports the more robust differentiation towards neural-like cells 
(Mumaw et al., 2010) or the Retinoic acid was reported to enhance skeletal 
myogenesis in hESC (Ryan et al., 2012). We investigated and validated the 
trophoblast markers expression by real-time PCR. Upon 72 hours of differentiation, 
there is up-regulation of various trophoblast markers, such as CDX2, DLX3, GATA3, 
TFAP2A, and HAND1, while down-regulation of pluripotency markers were seen, 
including OCT4, NANOG, and SOX2. The Caudal-related Homeobox-2 (CDX2) is a 
well-known transcription factor in trophectoderm lineage in hESC(Chen et al., 2013; 
Matin et al., 2004), which was also described in mouse system (Niwa et al., 2005). 
This transcription factor was also reported to be conserved target of OCT4 in hESC 
(Boyer et al., 2005). The GATA factors, especially GATA2 and GATA3 have been 
regarded as important trophectoderm markers (Hay et al., 2004; Xu et al., 2002), 
which were also reported to regulate the alpha subunit of chorionic gonadotrophin 
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gene expression in human choriocarcinoma cell line (Steger et al., 1994). A member 
of large homeobox gene family of transcription factors, Distal-less homeobox gene 3 
or DLX3 is expressed in the nucleus of major trophoblast cells from human first 
trimester placental explant (Chui et al., 2010). DLX3 was also shown to bind to the 
junctional regulatory element (JRE) of alpha subunit of chorionic gonadotrophin gene, 
which suggests the involvement of this transcription factor during placentation 
(Roberson et al., 2001). The basic helix-loop-helix protein HAND1 was reported to be 
expressed in the human pre-implantation blastocyst and trophectoderm derivation in 
vitro, which suggests its possible role during early trophectoderm lineage 
determination (Knöfler et al., 2002; Peiffer et al., 2007). Last trophoblast marker that 
was detected in our genes expression result is Transcription Factor AP-2α, which is 
known as trophectoderm specific marker and a transcription factor expressed in the 
cytotrophoblast cells and might involve in its differentiation (Hubert et al., 2010). 
This transcription factor was suggested to be involved in the TGF-β/SMAD-induced 
transcription process (Koinuma et al., 2009). TFAP2A also known to induce the 
expression of human chorionic gonadotrophin subunit alpha (CGA) and beta (CGB) 
(Johnson et al., 1997), placental lactogen, and corticotrophin releasing hormone 
(CRH) (Cheng et al., 2004). Also, it was reported to induce the expression od 
aromatase cytochrome P-450 or CYP11A1 in syncytiotrophoblast (Yamada et al., 
1995). Several trophoblast markers have been associated or affected by transcription 
factors that are important in maintaining pluripotency. The POU domain transcription 
factor POU5F1 or OCT4 is widely recognized as an essential transcription factor in 
maintaining stem cell pluripotency both in human and mice (Niwa et al., 2005; 
Reubinoff et al., 2000). OCT4 is known to be expressed from unfertilized oocytes, the 
ICM (Adjaye et al., 1999), primodial germ cells (Pesce et al., 1998), and epiblast of 
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pre-gastrulation embryo (Goto et al., 1999). Down-regulation of OCT4 expression in 
trophoblast differentiation and OCT4 knockout mutant embryo results in most 
trophoblast-like cells, which indicates the OCT4 is required to establish and maintain 
the pluripotency in the embryo (Nichols et al., 1998). OCT4 inhibition in hESC also 
leads to differentiation into trophoblast-like cells that confirms its critical role and 
suggests an early function of this transcription factor as a regulator in preventing the 
differentiation to trophoblast lineage (Hay et al., 2004; Matin et al., 2004; Niwa et al., 
2000). Besides OCT4, studies from human and mouse model indicate the involvement 
of homeobox protein NANOG and transcription factor SOX2 together with OCT4 to 
cooperatively maintaining pluripotency in embryonic stem cells (ESC) (Avilion et al., 
2003; Loh et al., 2006; Mitsui et al., 2003). It was reported that either TGF-β/Activin 
or BMP associated SMADs directly bind to the proximal promotor of NANOG 
regulating the self-renewal of ESC (Xu et al., 2008). In trophoblast derivation from 
ESC, it was reported the NANOG and trophectoderm marker CDX2 regulates each 
other, where the overexpression of NANOG suppressed the trophoblast markers 
expression and on the other hand the knockdown of NANOG up-regulated the 
trophoblast markers (Chen et al., 2009). Similar effect also observed by Adachi, et al. 
(2010), which reported down-regulation of SOX-2 in hESC caused trophectodermal 
differentiation. Based on the published work by Boyer, et al. (2005), approximately 
50% of promotor region occupied by OCT4 also targeted by SOX2 and almost 90% 
of binding sites occupied by both OCT4 and SOX2 also bound by NANOG, which 
the binding sites of all three transcription factors are located within close proximity in 
nearly all the genes they occupied together. In summary, the undifferentiated state of 
hESC is maintained under orchestrated system involving the cooperated works 
between OCT4, NANOG, and SOX2. 
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Because from our hESC differentiation towards trophoblast lineage resulted in mixed 
population of trophoblast cells and referring to the ability of trophoblast lineage to 
give rise to multiple cell types that build placenta, we would like to further investigate 
the cell types that belong to the trophoblast lineage by screening out the potential 
signaling molecules, such as cytokines and growth factors, in cell culture-based 
system on H1-differentiated trophoblast. Due to the number of cytokines/ growth 
factors that were used in subsequent differentiation, High Content Screening (HCS) 
was utilized to efficiently select the potential signaling molecules that affect the 
morphology of H1-differentiated trophoblast. From the HCS screening of the 72 
hours treated culture, the multinucleated syncytiotrophoblast came out as the most 
significant morphology observed in the system. From the quantification result of 
several morphology features and qualitative pictures generated from HCS first 
screening that indicate the tendency towards syncytiotrophoblast formation, three 
growth factors were selected from eleven-potential cytokines/ growth factors. 
The first growth factor selected from HCS system was BMP4, which is known as an 
important growth factor in inducing trophoblast lineage. The BMP4 alone treatment 
on H1-differentiated trophoblast interestingly supported the formation of 
syncytiotrophoblast. During BMP4-induced differentiation of hESC towards 
trophoblast lineage, BMP4 activates the BMP signaling as part of TGF-β signaling 
pathway by interacting with SMAD-1/5/8 for signal translocation into the nucleus. A 
recent study by Sudheer, et al. (Sudheer et al., 2012) reported the reduction of 
SMAD1, despite of BMP signaling, also GSK3b and DKK1 expression enhancement, 
which indicates the WNT activation. The elevation of GSK3b is known to induce the 
degradation of SMAD1 by phosphorylation at linker region (Sieber et al., 2009). The 
WNT signaling was previously reported to be essential in GCM1/SYNCYTIN-
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induced syncytial formation in choriocarcinoma cell line (Matsuura et al., 2011). In 
contrast, the activation of various trophectoderm markers, by BMP signaling via 
SMAD5, also directly activates CGA or the alpha subunit of hCG (Roberson et al., 
2001; Steger et al., 1994). Interestingly, the cAMP, which is the current proposed 
signaling pathway in trophoblast fusion, was reported to potentially enhance the 
BMP-induced transcription through PKA-mediated pathway in murine myoblast cell 
line (Ohta et al., 2008). To conclude, the BMP signaling coupled with FGF signaling 
inhibition supports the initial differentiation of hESC towards trophoblast lineage, but 
is being reduced during syncytial formation. Afterwards, the prolonged BMP4 
treatment without FGF signaling inhibitor on H1-differentiated trophoblast might be 
either an extended activation and maintenance of trophoblast markers and induction 
of hCG (marker of syncytiotrophoblast and precursor) or the already activated cAMP 
supports back the BMP signaling in further differentiation. 
Epidermal Growth Factor (EGF) is the next ligand selected from our screening that 
has positive regulation in syncytiotrophoblast formation. The EGF belongs to EGF 
family growth factors, which have various receptor subtypes from ErbB gene family 
of tyrosine kinase receptor, and is known to bind ErbB1 or EGFR (Dey et al., 2004; 
Oda et al., 2005). The EGF is expressed in the normal endometrium during menstrual 
cycle (Ejskjaer et al., 2005), in gestational decidua, and in first-, second-, and third-
trimester placenta during pregnancy (Hofmann et al., 1991), especially maternal 
uterine glands (Hempstock et al., 2004), and suggested to play an important role 
during decidualization and early embryonic implantation (Hoozemans et al., 2004). In 
the counterpart, the EGFR is expressed in the early stages of developing human 
embryo during peri-implantation period (Chia et al., 1995). EGF was reported to play 
a role in proliferation, differentiation (Li and Zhuang, 1997), and invasion of 
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trophoblast cells (Bass et al., 1994). Mutations in EGFR function are related with 
reduction of placental and embryonic growth in human (Fondacci et al., 1994). The 
TFAP2A, an important trophectoderm-specific transcription factor was reported to 
mediate EGF-dependent trophoblast invasion in primary trophoblast explant and 
trophoblastic cell line (Biadasiewicz et al., 2011). The EGF was reported to induce 
syncytialization of cytotrophoblast and secretion of human chorionic gonadotropin 
(hCG) and human placental lactogen (hPL) in vitro (Morrish et al., 1987). In the 
trophoblast differentiation, EGF was reported to stimulate hCG production in 
choriocarcinoma cell line, which hCG is a marker of syncytiotrophoblast (Benveniste 
et al., 1978; Morrish et al., 1987). The EGF was reported to transcriptionally activate 
chorionic gonadotrophin alpha gene through cAMP response element (Matsumoto et 
al., 1998). In other published work, EGF was reported to induce trophoblast 
differentiation by stimulating the phosphorylation or activation of the MAPK 
signaling pathway, especially signaling intermediate p38 (MAPK11/14) pathway 
(Johnstone et al., 2005) in trophoblast clinical explant (Maruo et al., 2011; Morrish et 
al., 1997). Interestingly, more recent publication investigate the interplay of cAMP 
and MAPK signaling pathway in hCG secretion and trophoblast fusion in 
choriocarcinoma cell line, which p38MAPK is the activated downstream of 
PKA/cAMP signaling pathway (Delidaki et al., 2011)and influence the activation of 
various syncytiotrophoblast markers, including GCMa and the syncytins (Matousková 
et al., 2006; Vargas et al., 2009; Yu et al., 2002).  
The last growth factor screened from HCS that induced the formation of 
syncytiotrophoblast is Keratinocyte Growth Factor/ Fibroblast Growth Factor-7 
(KGF/FGF-7), which is a paracrine mediator of epithelial-mesenchymal interactions 
in various organs (Rubin, 1995), including those of the reproductive tract, such as 
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ovary, uterus, prostate, and mammary gland (Cooke et al., 1998). The FGF7 
expression in the uterine has been identified in several species, including primates and 
human. The FGF7 binds to receptor belongs to FGFR, specifically FGF receptor 2IIIb 
(FGFR2IIIb), which is an alternative splice variant of the bek gene product and is 
present only on epithelial cells (Coulier et al., 1997). In primate, the expression of 
FGF7 in endometrial gland and trophoblast expression of KGFR indicated the FGF7 
role in early trophoblast development (Izumi et al., 1996; Pekonen et al., 1993). The 
FGF7 signal transduction is mediated through MAPK pathway and is significantly 
inhibited by PD-98059, MAPK signaling inhibitor, suggesting its signaling mediation 
via MAP kinase and PI-3 kinase-dependent signaling pathways (Szebenyi and Fallon, 
1999). One of the placenta-specific gene, plac1 is recently identified and suggested to 
has possible role in maternal-fetal interface during placental development (Cocchia et 
al., 2000), which is reported to be induced by FGF7 (Fant et al., 2002) and localized 
to membranous compartments in the apical domain of syncytiotrophoblast (Fant et al., 
2007). FGF7 with its receptor FGFR2b exhibited spatial overlap with PLAC1 
suggesting these regulatory interactions are physiologically consistent during 
gestation (Rawn and Cross, 2008). Even though the FGF7 and EGF signal 
transduction are mediated through the same MAPK pathway, interestingly, if the 
trophoblast under EGF treatment alone, no effect is observed on the PLAC1 
expression but potentiated the effect of FGF-7, which suggest the regulatory 
interaction of both growth factors (Massabbal et al., 2005). These data demonstrate 
PLAC1 expression is upregulated during trophoblast differentiation, localizing 
primarily to the differentiated syncytiotrophoblast.  
In conclusion, the highest percentage of syncytiotrophoblast formation (~90%) from 
HCS screening was obtained from the combinatorial treatment of BMP4, EGF, and 
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FGF7 for 72 hours on H1-differentiated trophoblast, which was H1 (hESC) pre-
treated with BMP4 and FGF-signaling inhibitor, SU5402 for three days. The 
syncytiotrophoblast is the only known trophoblast subtype exhibiting multinucleated 
properties. The immunofluorescence membrane and nuclei staining in combination 
with confocal microscopy were performed to validate the syncytial quantification in 
the BEF-treated culture. From our membrane staining result, we detected a decrease 
or diminish of E-cadherin signal in the cells that fused to form syncytiotrophoblast, 
while it still retained the signal in the membrane of mononuclei trophoblast cells. The 
similar phenomenon also observed in other published syncytiotrophoblast detection 
experiments, which suggests the down regulation of E-cadherin during the 
cytotrophoblast fusion into syncytiotrophoblast (Alsat et al., 1996; Coutifaris et al., 
1991). The elevation of E-cadherin expression was found in the pre-eclamptic 
placental tissues, which indicates the down regulation of E-cadherin correlates with 
trophoblast development (Li et al., 2003). The transcription factor TWIST was 
reported to capable of down regulating E-cadherin expression to induce terminal 
differentiation of trophoblast into syncytiotrophoblast (Getsios et al., 2000; Ng et al., 
2011). Based on those observations, the diminishment of E-cadherin expression in 
syncytiotrophoblast can be used as one of the criteria to mark the syncytial formation 
(Al-Nasiry et al., 2006; Chen et al., 2010; Wu et al., 2013). 
In order to further validate the syncytiotrophoblast that we obtained from the BEF-
treated culture, immunofluorescences staining of various syncytiotrophoblast known 
markers were done. The mechanism of the trophoblast fusion into syncytial form is 
still not completely understood, especially in human. The most acceptable theory of 
trophoblast fusion is the mediation by GCM1 transcription factor (Knerr et al., 2005). 
The positive and intense transcription factor GCM1 staining in the cells nuclei of 
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BEF-treated culture, especially the multinucleated syncytiotrophoblast, proved the 
differentiated trophoblast identity in the culture. The GCM1 expression in the other 
treatment and control cultures indicated the trophoblast cells are ready to differentiate 
into either one of villous or non-villous pathways. According to the published work 
by Baczyk, et al. (2009), GCM1 gene knock down in the placental villous and 
extravillous explants caused inhibition of syncytiotrophoblast formation and 
extravillous trophoblast proliferation, respectively, which means the GCM1 
involvement in trophoblast differentiation into both pathways.  
The other well-known syncytiotrophoblast markers are the endogenous retroviral 
envelope proteins, Syncytin-1 and Syncytin-2, which both are abundantly expressed 
in the human placenta, especially syncytiotrophoblast (Mi et al., 2000). Even though 
the syncytin-1 and syncytin-2 has similar structure and fusogenic capability (Blaise et 
al., 2005), each of them is mediated through different receptors (Blaise et al., 2003; 
Blond et al., 2000; Esnault et al., 2008). Different from the GCM1-downstream direct 
activation of syncytin-1, the syncytin-2 depends on the carbohydrate transducer, 
MFSD2 activation (Esnault et al., 2008; Liang et al., 2010). Also, it was reported that 
abnormalities in placental development and pre-eclampsia disorders during pregnancy 
are commonly associated with alteration in syncytin-1 expression (Knerr et al., 2002; 
Lee et al., 2001), while the syncytin-2 has more immunosuppressive-related role  
(Mangeney et al., 2007) and trisomy21-affected trophoblastic differentiation 
abnormalities (Malassine et al., 2008). The positive results of syncytin-1 
immunostaining in the culture treated with BEF showed the localization of syncytin-1 
evenly distributed in the cytoplasmic region of syncytiotrophoblast, which supports 
the syncytial identity. The activation of GCM1 in the cytotrophoblast or villous 
cytotrophoblast is known to affect the downstream genes including ervwe1 that 
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encodes fusion factor syncytin-1 (Yu et al., 2002). It was reported in the same 
publication that knocked down of syncytin-1 inhibited the syncytial formation of 
primary trophoblast, supporting the essential role of syncytin-1 in trophoblast fusion. 
Intriguingly, it was reported that the syncytin-1 expression was repressed by CpG 
methylation in non-placental cells, while its expression is abundant in placental 
trophoblast (Matousková et al., 2006). Finally, the functional validation of the 
syncytial formation in our experiment is the measurement of hCG expression from the 
culture. The hCG is known to be one of the most important hormone produced by 
trophoblast cells, which functions to maintain the corpus luteum during early 
gestation (Jameson and Hollenberg, 1993; Maston and Ruvolo, 2002; Srisuparp et al., 
2001). The villous cytotrophoblast and syncytiotrophoblast is known to produce hCG 
during pregnancy (Snegovskikh et al., 2007; Yang et al., 2003). Interestingly, the 
hCG was also reported to increase the spontaneous differentiation of isolated 
cytotrophoblast clinical explant into syncytiotrophoblast (Cronier et al., 1994; Shi et 
al., 1993). The aberrant expression of hCG has been associated with defect in 
trophoblast differentiation into syncytiotrophoblast in several pregnancy pathology 
(Frendo et al., 2001; 2000; Massin et al., 2001). The cAMP and MAPK signaling 
pathway are known to interplay and induce the expression of hCG in placental 
trophoblast and syncytiotrophoblast (Delidaki et al., 2011; Ge et al., 2011; LiCalsi et 
al., 2000). From our results, the culture that was treated with BEF generated the 
highest percentage of syncytial formation, which also has the highest hCG production 
measured. Thus, we managed to generate syncytiotrophoblast from our culture that 
exhibits syncytiotrophoblast known markers and also at least the similar functional 
characteristic in producing hCG, which is one of the functional marker for 
syncytiotrophoblast formation. 
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5.2. Molecular Pathways in Syncytiotrophoblast Invasiveness 
It is commonly recognized that the human embryonic implantation, which involving 
trophoblast invasion into maternal uterine wall, mimics the metastatic event in cancer 
(Papaioannou, 1993; PIERCE, 1983). However, due to the ethical and technical 
concern, one of the most important events during gestation remains unexplored. The 
morphological  evidence  from  Carneige’s collection shows that as early as 7 days post 
conception, the only blastocyst-originated cell type in the direct connection with 
maternal side is the trophoblast, especially syncytiotrophoblast (HAMILTON et al., 
1943). Unfortunately, no molecular data has been generated from any of those 
samples, which the technology development was limited at that time. In order to 
further investigate the early embryonic implantation period, Heuser & Streeter (1941) 
utilized macaque monkey as a primate model, which the section of the early 
embryonic attachment and implantation shows a group of invading multinucleated 
trophoblast at the fetal-maternal point of connection (Enders et al., 1983). Those 
evidences then suggest the involvement of early and invasive syncytiotrophoblast in 
penetrating the maternal uterine wall in human. Therefore, the emergence of 
syncytiotrophoblast from our cytokines/ growth factor-based differentiation screening 
encourage us to investigate its possibility of exhibiting invasive properties. Another 
reasons that support us to investigate the invasive properties possibility in 
syncytiotrophoblast are the optimization of initial H1-to-trophoblast differentiation 
period by aiming the earliest commitment time, which is 72 hours of SB treatment. 
This time length is similar with the GCM1 up regulation in the H1-differentiated 
trophoblast, which is obtained from RNA sequencing that is available in our lab. 
There have been many reported the similarities in various aspects between human 
embryonic implantation and cancer metastasis. The embryonic origin of tumours were 
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firstly described by Lobstein and Recamier in 1892, which later then further described 
by Dr.Pierce stated the embryonic cells and tumour cells had a lot of similarities and 
tumourigenesis in terms of continuous proliferation of the intracorporeal embryonic 
cells. Later, it was also pointed out that the formation of cancer cells was the result of 
reactivation of repressed gene in the process of normal embryonic development 
(Williams et al., 1993). Several evolutionary conserved pathways in developmental 
including Notch, BMP, Wnt, FGF, and Hedgehog signalling pathway, are essential 
for embryo development by regulating various cellular activities and morphogenesis 
(Wang and Steinbeisser, 2009). Interestingly, more recent publication reported that 
orchestra of Notch, BMP, Wnt, FGF, and Hedgehog signalling pathways is also 
indispensably involved in carcinogenesis (Katoh, 2007). The advances and 
development in developmental biology, molecular biology, tumour immunology, and 
experimental embryology, generated evidences that confirm the correlation between 
the development of early embryo and tumourigenesis (Monk and Holding, 2001). 
Multiple criteria have been used to investigate the metastatic stage in cancer, such as 
the capability to invade and migrate (Chambers et al., 2002). The cancer invasion and 
migration involves the penetration to the neighboring healthy adjacent tissue (Gupta 
and Massagué, 2006). In this process, several lytic enzymes, for example Matrix 
Metallo-Proteinases (MMPs) are secreted, which then degrade the extracellular matrix 
(ECM) and, thus facilitate migration (Deryugina and Quigley, 2006). Various studies 
connected the MMPs inhibition by natural and synthetic inhibitors, for example tissue 
inhibitors of matrix metalloproteinase (TIMPs) with a correlating inhibition of tumour 
invasion (Lynch and Matrisian, 2002; Sounni and Noel, 2005). On the other hand, any 
up-regulation of MMPs by inducers or transcriptional activation usually cause 
enhanced tumor cell invasion, which observed in vivo by histology, or appearance of 
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tumor cells in distant sites in model system and in vitro by ECM invasion, for 
example matrigel (Demers et al., 2005; Liotta et al., 1980; Stamenkovic, 2000). 
Numerous matrix metalloproteinase have been identified to play some role in 
metastasis of different type of cancers (Egeblad and Werb, 2002). Even in human 
pregnancy, several matrix metalloproteinases are identified and suggested to play role 
in maternal arterial vessel invasion by trophoblast establishing the maternal 
circulation (Vegh et al., 1999; Zhu et al., 2012). One of the most renowned MMPs as 
a major regulator in tumour invasion during metastasis is membrane-bound matrix 
metalloproteinase type-1 (MT1-MMP) or MMP14 (Szabova et al., 2008). 
Interestingly, based on our lab available RNA-seq data of H1 differentiation towards 
trophoblast lineage, the MMP14 is significantly up-regulated and considered in the 
top 5% of total up-regulated genes. MT1-MMP is one of six only known membrane-
type matrix metalloproteinases that was firstly discovered MT-MMPs in human by 
RT-PCR-based cloning strategy using degenerate oligonucleotides referred from 
MMPs conserved region on the RNA od placental tissue (Sato et al., 1994). MMPs 
associated with the cell surface of cancers are critical for the invasive phenotype of 
tumor cells degrading collagen-containing milieu surrounding tumour cells, which is 
more applicable for migration and invasion as compared to soluble MMPs (Ellerbroek 
and Stack, 1999; Seiki, 1999). The mature or activated MT1-MMP is a potent 
surface-bound proteinase with the capability to degrade type I collagen, which is one 
of the ECM components, more efficiently than type II or III collagens (Ohuchi et al., 
1997). In correlation with human embryonic implantation, it is known that the 
collagen type-1 is the most abundant collagen in human endometrium wall (Stovall et 
al., 1992; Wonodirekso et al., 2000). Therefore, it is suspected that the early invasive 
syncytiotrophoblast might express the MT1-MMP during endometrial wall invasion, 
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where collagen type-1 as a main substrate of MT1-MMP and is abundant in the 
uterine wall. In order to clarify that, we did immunofluorescence staining of MT1-
MMP using antibody recognizing its catalytic domain on the BEF-treated culture. As 
expected, we observed an intense signal of MT1-MMP expression on 
syncytiotrophoblast derived from our culture treatment. The utilization of MT1-MMP 
catalytic domain antibody prevents the false positive of capturing the inactivated 
MT1-MMP, which the catalytic domain is specifically exposed when the MT1-MMP 
is already activated (Löffek et al., 2011). It is known that some MMPs, including MT-
MMPs expressed as pro-forms (zymogen) or inactive form, which then must undergo 
further sequential proteolysis of the propeptide that blocks the active site (Murphy et 
al., 1999; Ra and Parks, 2007). The MT1-MMP is expressed in 60kD pro-form 
zymogen and is activated by furin-like convertases, which cleave at the Arg108-Arg-
Lys-Arg motif between the pro-peptide and the catalytic domain (Sato et al., 1996; 
Yana and Weiss, 2000). The MT1-MMP activation by furin cleavage results in 54kD 
active form with addition of a series of further degraded forms ranging from ~44 to 40 
kD (Hernandez-Barrantes et al., 2000; Lehti et al., 1998). In order to assess the 
multiple forms of MT1-MMP, we did western blot of BEF-treated culture and found 
similar form arrangement, which is around three different forms of MT1-MMP were 
observed, the inactive ~60kD, the active ~54kD, and further degraded ~42kD form. 
During cancer metastasis, the existence of MT1-MMP in assisting invasion and 
migration is usually integrated with a specialized cell structure called Invadopodia 
(Watanabe et al., 2013). Invadopodia is a subcellular structure that selectively 
presents in invasive as compared to non-invasive cancer cells and has significant role 
in mediating the invasion process, which is ECM degradation (Buccione et al., 2004). 
The formation of invadopodia involves cytoskeleton and F-actin focal rearrangement 
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with dependence on src kinase and expresses focal adhesion proteins, integrins, and 
proteases (Stylli et al., 2008). Since the invadopodia is a structure that is rich in 
filamentous actin (F-actin), we tried to find this structure in our BEF-derived 
syncytiotrophoblast by immunofluorescence for F-actin and active MT1-MMP. 
Intriguingly, our data demonstrated the multinucleated cell (syncytiotrophoblast) 
compartment with focal rearrangement and MT1-MMP   is   localized  at   the   “foot”  of  
this structure. There are three major steps in invadopodia formation, which begin with 
disintegration of focal adhesion by phosphorylation of tyrosine kinase FAK releasing 
active SRC to support the phosphorylation of invadopodia-associated proteins and 
increase the invadopodia formation (Chan et al., 2009). After initiation by SRC 
signaling, the next step is the invadopodia assembly step by recruitment of TKS5 and 
Cortactin, which both molecules bind to various actin key regulators, such as NCK1,2, 
N-WASP, ARP2/3, and GRB2 (Oikawa et al., 2008). These molecules then interacts 
with WASP interacting protein (WIP), which an important molecule in invadopodia 
formation (Gimona et al., 2008). The cortactin is phosphorylated by several kinases, 
such as SRC, PAK, ERK families (Weaver, 2008). Also, the EGF induction leads to 
tyrosine (Tyr) phosphorylation of cortactin, which then dissociates from cofilin and 
initiating actin polymerization followed by invadopodia formation (Oser and 
Condeelis, 2009; Yamaguchi et al., 2005). Finally, during the invadopodia maturation 
step, the TKS4 and cortactin facilitate the MT1-MMP trafficking to focal point of 
invadopodia thus enabling the ECM degradation (Artym et al., 2006; Buschman et al., 
2009). To conclude, the EGF in final BEF combinatorial treatment might have 
supported the invasive characteristic of syncytiotrophoblast derived from the H1-
differentiated trophoblast, besides to also play some role in trophoblast fusion into 












The ethical and technical concerns have left human early embryonic implantation and 
placentation unexplored. Besides that, the uniqueness in human embryonic 
implantation and placentation also make the other animal models, for example mice, 
unsuitable to be utilized as a proxy to human. Therefore, by utilizing the pluripotency 
of human embryonic stem cells (hESC/hESC), we explored the potential of hESC to 
derive various cell types that belongs to trophoblast lineage, which is the specialized 
lineage that give rise to proper placenta. By utilizing H1 pluripotent stem cell line that 
was firstly differentiated towards trophoblast lineage by BMP4-SU5402 (SB) 
treatment and screening through various potential growth factors and cytokines using 
High Content Screening (HCS) system, we managed to shortlist three growth factors 
that significantly induce the formation of syncytiotrophoblast. Similar study done by 
Sudheer, et al. (2012) utilized the BMP4 and FGF-signaling inhibitor to derive 
syncytiotrophoblast from hESC, as compared to our protocol, we managed to 
establish a differentiation protocol that increases the efficiency and the purity of the 
syncytiotrophoblast formation. The combination of Bone Morphogenetic Protein 4 
(BMP4), Epidermal Growth Factor (EGF), and Fibroblast Growth Factor 7 or 
Keratinocyte Growth Factor (FGF7/ KGF), induced the highest percentage of 
syncytiotrophoblast (~90%) formation. Several syncytiotrophoblast markers 
validation, such as GCM1 and SYNCYTIN1, by immunofluorescence staining 
supports the syncytiotrophoblast identity. Moreover, the human chorionic 
gonadotrophin (hCG) measurement was also performed to further functionally 
validate the syncytiotrophoblast derived from our culture. The BEF treated culture 
showed the highest level of hCG secretion and correspond to the highest percentage 
of syncytiotrophoblast formation. 
We were intrigued by the possibility that our derived syncytiotrophoblast might be 
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similar to those of early invasive syncytiotrophoblast, but because it is impossible to 
gain access into early human embryonic implantation, any knowledge to this early 
syncytiotrophoblast is largely unknown. Referring to the classic Carneige collection 
of sections of early human embryonic implantation and some insights from the 
macaque primate model, it was shown that early syncytiotrophoblast is likely to 
exhibit invasive features and was the first blastocyst-origin cell type in direct contact 
with maternal side, thus was suggested to play the role in invading the maternal 
uterine wall to attach the embryo. Based on those observations and a well-accepted 
idea that human embryonic implantation process is similar to the metastatic event in 
cancer, we investigated the existence of several main cancer metastatic features in our 
syncytiotrophoblast, such as invadopodia formation accompanied by MT1-MMP 
expression. Interestingly, we demonstrated the formation of invadopodia structure 
with positive expression of MT1-MMP in our multinucleated syncytiotrophoblast. 
Therefore, this study clearly demonstrates the existence of invadopodia formation 
with MT1-MMP expression in syncytiotrophoblast cells, which are commonly 
accepted as non-invasive type of trophoblast cells.  
This study provides the promising preliminary results for investigating the invasive 
characteristic of syncytiotrophoblast by demonstrating the invadopodia formation 
with MT1-MMP expression. However, the detailed molecular pathways governing the 
formation of syncytiotrophoblast with invasive characteristic was not covered in this 
study due to the time limitation. Also, the functional study of the syncytiotrophoblast 
invasive characteristic was not optimized in this project because of the technical 
challenges and time concern. Thus, various interesting works are still to be done to 
further assess and investigate the molecular and functional aspects of this early 
invasive syncytiotrophoblast. 
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 The clear demonstration of invasiveness features in syncytiotrophoblast from this 
study provides a promising base to further explore this early-multinucleated 
trophoblast that has been overlooked for decades, which actually hold a very crucial 
role in human pregnancy. Some further interesting next steps that can be done to 
investigate this invasive syncytiotrophoblast including: 
 Functional invasion study utilizing various ECM component, especially 
fluorescence-labelled collagen type-1 to observe and measure the 
syncytiotrophoblast active invasion capability. 
 Flow cytometry-based cell sorting for selecting the active MT1-MMP 
positive syncytiotrophoblast to obtain invasive syncytiotrophoblast with high 
purity for further downstream experiments. 
 Global gene expression study of invasive syncytiotrophoblast, for example 
RNA sequencing, to deeply investigate the signaling pathways that govern the 
fusion of trophoblast and its invasive features with a high chance of novel 
genes or markers discovery. 
 The sorted invasive syncytiotrophoblast then can be injected into the mice to 
observe its capability to invade as functional validation in vivo. 
In more general view and ideal condition, the information gained from the global 
molecular study of invasive syncytiotrophoblast will be useful to compare and 
investigate the metastasis event in cancer for drug candidate discovery. Finally, the 
fact that human implantation and placentation are very unique and complex process, 
thus any information gained from the any model will be regarded as a piece of tile in 
an effort to complete the growing puzzle. Therefore, by also looking at the promising 
fundamental evidence of invasive syncytiotrophoblast derived from this project, I do 
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